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ABSTRACT
OBJECTIVE:
 To study the correlation between proportional pulse pressure and ejection fraction in
heart failure patients and the prognostic value of proportional pulse pressure in a
patient with heart failure.
RESULTS:
Highly significant ( p value <0.001) association observed between ejection
fraction and breathlessness on exertion, orthopnea, elevated jugular venous pressure,
proportional pulse pressure, systolic blood pressure, pulse pressure, third heart sound
and basal crepitation. The association is more (Pearson chi square value is 72.11) for
pulse pressure as compared to other parameter. The correlation of proportional pulse
pressure, systolic blood pressure, and pulse pressure with ejection fraction showed
moderate positive correlation in initial assessment. During follow up moderate
positive correlation for proportional pulse pressure was maintained. The correlation of
systolic blood pressure and pulse pressure with ejection fraction was increased to
strong positive correlation. The correlation coefficient regression line was linear
positive for all the three parameters. After optimization of treatment, the improvement
in proportional pulse pressure correlates with increased ejection fraction.
CONCLUSION:
The proportional pulse pressure showed moderate positive correlation with
ejection fraction. The proportional pulse pressure had good specificity for detecting
patients with heart failure with reduced ejection fraction. The proportional pulse
pressure was a good prognostic indicator in heart failure patients, low proportional
pulse pressure associated with poor outcome.
KEY WORDS: pressure, pulse pressure, blood pressure, proportional pulse pressure,
ejection fraction, heart failure
1AIM OF THE STUDY
The correlation between proportional pulse pressure and ejection
fraction by 2D Echocardiogram in heart failure patients.
Objectives:
1. To study the correlation between proportional pulse pressure and
ejection fraction in heart failure patients.
2.  To study the prognostic value of proportional pulse pressure in a
patient with heart failure.
2INTRODUCTION
A common clinical syndrome with raising incidence and
prevalence is Heart failure (HF). Countless large clinical trials done over
the use of pharmacological therapy and devices has resulted in a raising
use of evidence based therapy in heart failure management. In spite of
these advances the morbidity and mortality of heart failure patients
endures to stay high. Adherence to guidelines results in enhanced
outcomes of heart failure patients. Evidence based therapy is the
important milestone in successful heart failure management for
caregivers [1].
DEFINITION:
The American Heart Association / American College of
Cardiology guidelines, heart failure is defined as “a complex clinical
syndrome that can result from any structural or functional cardiac
disorder that impairs the ability of the ventricle to fill or eject blood” (1,
2). The guidelines underscore that “it is mainly a clinical diagnosis that is
based on a careful history and physical examination”. The word “heart
failure” is preferred over “congestive heart failure” because not all the
heart failure patients had volume overload.
3INCIDENCE AND PREVALANCE:
The overall prevalence of heart failure in the adult population in
developed countries is 2 %.It  prevalence follows an exponential outline
and rising with age. It affects 6-10% of people over the age of 65years.
The relative incidence of heart failure is lower in women in difference to
men. Because of their longer life expectancy, women constitute one half
the case of heart failure. The prevalence of heart failure is believed to be
increasing in portion because of current therapies for cardiac disease and
enable patients to survive longer [4].
CLASSIFICATION:
Heart failure was beforehand thought to arise in the setting of a
depressed left ventricular ejection fraction. Though, epidemiologic
studies clarified that approximately nearly half of patients who develop
heart failure have a normal or preserved ejection fraction (EF ?50%) [1].
Accordingly, the historical words “systolic” and “diastolic” HF
have been abandoned. Now heart failure patients broadly categorized
1. HF  with a reduced EF (HFrEF; formerly systolic failure)
2.  HF with a preserved EF (HRpEF; formerly diastolic failure)
4NYHA CLAAIFICATION:
ETIOLOGIES OF HEART FAILURE
Each condition which leads to an alteration in left ventricular
structure or function can predispose patients to develop heart failure.
Even though the etiology of heart failure in patients with a preserved
ejection fraction differs from that of patients with reduced ejection
fraction, there is substantial overlap between the aetiologies of these two
conditions [1].
5Reduced Ejection Fraction (<40%):
Coronary artery disease ? Myocardial infarction
? Myocardial ischemia
Chronic pressure overload ? Obstructive valvular disease
? Hypertension
Chronic volume overload ? Regurgitantvalvular disease
? Intra cardiac shunting
? Extracardic shunting
Chronic lung disease ? Corpulmonale
? Pulmonary vascular disease
? Pulmonary embolism
Non ischemic dilated
cardiomyopathy
? Familial/genetic disorder
? Infiltrative disorder
? Metabolic disorder
? Viral
? Chagas disease
Toxin / drug induced ? Alcohol
? Cocaine
?  Radiation
Disorder of rate and rhythm ? Tachycardia
? Bradycardia
?   Heart block
6Preserved Ejection Fraction ( EF>40 – 50%):
Pathologic hypertrophy High-output states
? Primary
Hypertrophic cardiomyopathy
? Secondary
1. Hypertension
2. Restrictive cardiomyopathy
 (amyloidosis, sarcoidosis)
3. Infiltrative disorder
4. Endomyocardial disorder
? Metabolic disorder
– thyrotoxicosis
? Nutritional disorder
(beribery)
? Systemic AV shunting)
? Chronic anemia.
7PATHOPHYSIOLOGY
In  response  to  a  sequence  of  complex  events  that  occur  at  the
cellular and molecular levels results in left ventricular remodelling is the
basic pathophysiology of heart failure with reduced ejection fraction.
Current studies have shown that left ventricular remodelling can be
reversed following medical and device therapy and that reversed left
ventricular remodelling is associated with improved clinical outcomes in
patients with heart failure with reduced ejection fraction. Indeed, one of
the aims of therapy for heart failure is to prevent and/or reverse left
ventricular remodelling[1].
Fig;1
8Fig. 2
The compensatory mechanisms are,
(1) Activation of the renin-angiotensin-aldosterone (RAA) and
adrenergic nervous systems, which are responsible for
maintaining cardiac output across increased retention of salt and
water (Fig.2) and increased myocardial contractility.
9(2) Activation of a family of countervailing vasodilatory molecules,
including the atrial natriuretic peptide and brain natriuretic
peptide, prostaglandins (PGE2and PGI2), and nitric oxide (NO),
that results in stopping the excessive peripheral vascular
vasoconstriction[1].
CLINICAL HISTORY AND EXAMINATION
The cardinal symptoms of heart failure are fatigue and shortness
of breath. In the early stages of heart failure, dyspnoea is noted only
during exertion. Though, as the illness progresses, dyspnoea occurs with
less strenuous activity, and it in the end may occur even at rest. The
basis of dyspnoea in heart failure is plausibly multifactorial. The most
vital mechanism is pulmonary congestion with accumulation of
interstitial or intra-alveolar fluid, which activates juxta capillary J
receptors, which in coil stimulate the rapid, shallow breathing which is
characteristic of cardiac dyspnoea.
Orthopnoea (shortness of breath after lying flat) and paroxysmal
nocturnal dyspnoea (sudden onset of nocturnal shortness of breath) are
both manifestations of heart failure precipitated by increased venous
return. The other clinical parameters are elevated jugular venous
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pressure (JVP), peripheral oedema, palpable liver, basal crepitation,
tachycardia, and a third heart sound. Nocturia is common in heart failure
will results in insomnia.
A short overview of certain terminologies is as follows;
DYSPNEA:
Dyspnoea is an atypical awareness of breathing occurring at rest
and/or minimal  exertion. It is a subjective experience perceived and
reported by an affected patient. Dyspnoea on exertion (DOE)may occur
normally, but is considered as symptom of heart diseasewhen it occurs
at a level of activity that is well tolerated usually [3].
ORTHOPNEA:
Orthopnoea is described as dyspnoea occurring in the recumbent
position, and it is relieved by sitting or standing. In recumbent position
of heart failure patients causes an increases in left atrial pressure, and
there by resulting in pulmonary congestion and severe dyspnoea [3].
PAROXYSMAL NOCTURNAL DYSPNOEA:
Defined as acute episodes of severe shortness of breath and
coughing that usually occur at night and awaken the patient from nap,
normally 1–3 h afterward the patient sleeps. Cardiac asthma is closely
related to paroxysmal nocturnal dyspnoea[3].
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EDEMA:
Edema is difined as collection excess amount of fluid in the intra
vascular or interstitial space. Conventionally, it is divided into pitting
and non pittingedema. Pitting edema is the important feature in heart
failure. It is usually examined in dependent area, over the bony
prominence.
PULSE:
It is the pressure wave that travels alongside the walls of arteries
when blood is ejected from left ventricle into aorta across systole
resulting  in  expansion  of  artery  that  is  palpated  as  arterial  pulse.  The
transmission of pressure pulse wave is independent to velocity of blood
flow and much faster than it. Normally arterial pulse ends in arterioles
and there are no capillary pulsations. Except jugular vein, no pulsations
in other veins. The amplitude of arterial pulse generally depends on
pulse pressure[3].
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BLOOD PRESSURE:
Blood pressure (BP) is the pressure, measured by sphygmo-
manometry as millimetres of mercury. It is divided in to systolic blood
pressure and diastolic blood pressure. Systolic blood pressure is the
pressure measured during peak of contraction of left ventricle. And, the
diastolic blood pressure is the pressure measured during end of
ventricular diastole. Systolic blood pressure mainly depends on stroke
volume and diastolic blood pressure mainly depends on peripheral
vascular resistance. In old age due to loss of elasticity of vessels results
in decrease in peripheral vascular resistance and there dy low diastolic
blood pressure. In acute shock, blood loss, and acute left ventricular
failure decrease in stroke volume results in low systolic blood pressure.
PULSE PRESSURE:
 Pulse pressure = Systolic blood pressure – Diastolic blood pressure
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? It is the difference between systolic blood pressure and diastolic
blood pressure. It depends on Stroke volume and Elasticity of
arteries.
? Pulse pressure is directly proportional to stroke volume.
? Stroke volume is affected by heart rate, total peripheral resistance
(TPR) & mean systemic filling pressure.
? Stroke volume is decreased with increased heart rate.
TOTAL PERIPHERAL RESISTANCE:
The rise in total peripheral resistance results in constriction of
arterioles leads to less blood flows to tissues and there by decrease in
venous return and stroke volume.
MEAN SYSTEMIC FILLING PRESSURE:
Mean systemic filling pressure is directly proportional to venous
return.   If this pressure increases lead on to increase in venous return
results in increases Stroke volume.
ELASTICITY OF ARTERIES:
Pulse pressure is inversely proportional to elasticity of arteries. In
more elastic arteries pulse pressure decreases. With aging, arteries are
become less elastic resulting in high pulse pressure.
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PROPORTIONAL PULSE PRESSURE:
It is a ratio of pulse pressure and systolic blood pressure.
Proportional pulse pressure =
(In percentage)
Pulse pressure
X 100
Systolic blood pressure
Proportional pulse pressure showed good correlation with cardiac
index & stroke volume compared to pulse pressure. When proportional
pulse pressure was less than 25 percent, it reflects a cardiac index below
2.2 lit/min/m2.
Proportional pulse pressure is a significant risk indicator in heart
failure, in advanced heart failure patient whose treated optimally, its
higher value related to favourable outcome and less than 25 percent
related to poor outcome.
JUGULAR VENOUS PRESSURE (JVP):
It is the indirect measurement of right atrial pressure. During
cardiac cycle, fluctuations in right atrial pressure produce a pulse that is
conducted backwards into jugular veins. Normal jugular venous
pressure is 6 mmhg which is corresponds to presence of jugular venous
pulse 4 cm above the sternal angle or 9 cm above the right atrium[3].
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Conditions with elevated jugular venous pressure [3] is
1. Congestive heart failure,
2. Corpulmonale,
3. Pulmonary embolism,
4. Right ventricular infarction,
5. Tricuspid valve disease,
6. Tamponed & Constrictive pericarditis.
THIRD HEART SOUND:
The third heart sound (S 3) is a low-frequency, brief vibration
occurring in early diastole due to rapid filling of right or left ventricle
(S3) following atrio ventricular valve opening. “S3 is physiological in
children and young adults but usually disappears after the age of 40[3]. It
also occurs in high-output states caused by anaemia, fever, pregnancy
and  thyrotoxicosis.   After  the  age  of  40  years  S3  is  nearly  always
pathological, usually indicating left ventricular failure and less
commonly, mitral regurgitation or constrictive pericarditis” by
hutchinsons clinical method [3].
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HEART FAILURE DIAGNOSTIC CRITERIA:
FRAMINGHAM CRITERIA:
Major criteria: Minor criteria:
? Paroxysmal Nocturnal dyspnea
or orthopnea?
? Neck vein distension?
? Pulmonary basal crepitation ?
? Cardiomegaly (>55%)?
? Acute Pulmonary edema?
? Third heart sound?
? Increased venous pressure
?16cm of water?
? Circulatory time ?25 s?
?Hepato jugular reflux?
? pedal oedema?
? Nocturnal cough?
? Dyspnoea on exertion?
? Hepatomegaly?
? Pleural effusion?
? Vital capacity decreased 1/3 from
Maximum?
? Tachycardia, heart rate
of?120/min?
?
Major or minor criteria: Weight loss ?4.5 kg to 5kg in response to
treatment.
*Heart failure present with 2major or 1major and 2minor criteria.
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BOSTON CRITERIA:
Category 1: (points) Category 2: (points) Category 3: (points)
History:
? Rest dyspnea(4),
? Orthopnea (4)
? Paroxysmal nocturnal
dyspnea (3)?
? Dyspnea on walking
on level (2)?
? Dyspnea on climbing
(1)?
Physical examination:
? tachycardia (1–2)
?? ?elevated Jugular
venous Pressure
(1–2)
? pulmonary crepitation
(1–2)?
? Wheezing (3)?
?? Third heart sound
(3)
Chest radiography:
? Alveolar pulmonary
edema  (4)?
? Interstitial pulmonary
edema   (3)?
? Bilateral pleural
effusions (3)?
? Cardiothoracic ratio
?0.55 (3)?
? Upper zone Flow
redistribution (2)
? Definite heart failure - 8–12 points,
? Possible heart failure  5–7 points,
? Heart failure unlikely ?4 points
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BIOCHEMICAL MARKERS IN HEART FAILURE:
The pre-pro hormone brain natriuretic peptide is a precursor of
brain natriuretic peptide and N-terminal pro-brain natriuretic peptide. It
contains 134-amino-acid peptide. It is produced in the myocytes and
metabolised to pro hormone brain natriuretic peptide contains 108
amino acids. Pro hormone brain natriuretic peptide is metabolised by a
circulating endo protease into two polypeptides: one is inactive N
terminal-pro-brain natriuretic peptide and another one is a bioactive
peptide brain natriuretic peptide. Brain natriuretic peptide and N-
terminal-pro-brain natriuretic peptide have been used to differentiate
between cardiac and non-cardiac causes of breathlessness in heart
failure patients.
ELECTROCARDIOGRAPHY:
The basic investigation electrocardiography primarily used to
know the etiology of heart failure and then complication of heart failure.
In coronary artery disease it shows which vessel affected, in
hypertensive patients it shows ventricular hypertrophy. The QRS
widening i.e. more than 120 ms, is common feature in patients with
dilated cardiomyopathy related heart failure (sensitivity is 30%)[2].
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CHEST RADIOGRAPHY:
Figure 3
(A) Explains The Important Signs Of Heart Failure.
(B) Shows Cardiomegaly And Right Plural Effusion.
20
ECHOCARDIOGRAM:
According to American Society of Echocardiography-European
Association of Echocardiography guidelines, “Echocardiogram is an
important tool to assess the ventricular function and underlying
structural lesion. Assessment of left ventricular systolic function in
biplane Simpson’s method is routinely utilized in clinical use. It is a
valuable and simple tool in measuring left ventricular volumes and
assessment of stenosis and regurgitation. Echocardiography plays a vital
role in the diagnosis of patients with heart failure, in part because the
physical examination, electrocardiogram and / or chest radiograph do
not provide information that distinguishes diastolic from systolic heart
failure. Trans mitral and pulmonary flow velocities are used in the
assessment of diastolic dysfunction. Variation in the pattern of these
velocities gives vision into left ventricular diastolic function and
prognosis. Some amount of grade I diastolic dysfunction is seen in most
of the patients and it has to be correlated with the clinical symptoms and
signs. It mainly helps to differentiates constrictive pericarditis and
restrictive cardiomyopathies”. Echocardiogram ought to be performed in
all patients with symptoms or signs of heart failure because it is a very
useful, cheaper, easily available and non-invasive tool.
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ROLE OF ENDOMYOCARDIAL BIOPSY (EMB):
Endo myocardial biopsy is useful in identify a behind pathology of
dilated cardiomyopathies like myocarditis and cardio tropic viruses. In
selected cases of infiltrative diseases to found exact aetiology of heart
failure, it can be used to diagnose the cause. Endo myocardial biopsy
can be done through internal jugular vein or femoral vein. It is a safe
technique.
The current recommendation for indication of endo myocardial biopsy is
1. Patients with new onset of heart failure for less than three months
duration,
2. Patients with  haemodynamic compromise with or without dilated
ventricles,
3. Evidence of arrhythmias and its fail to respond to usual tretment
for 1 to 2 weeks of duration.
REVIEW OF
LITERATURE
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REVIEW OF LITERATURE
This study aims to find out the correlation between proportional
pulse pressure and ejection fraction in heart failure patients.
Secondarily, to study the prognostic value of proportional pulse pressure
in a patient with heart failure.
Although, epidemiological studies in the past decade fail to give
data about importance of physical signs in patients with heart failure, the
cardiovascular physical examination remains a basis for diagnosis and
therapy in patients with heart failure till today in many occations.
Proportional pulse pressure in heart failure:
In  1989,  Stevenson  LW  et  al  (8),   compared  physical  signs  of
heart failure in patients with known chronic heart failure with ejection
fraction is 18 % +/- 6 %. In this study they found when pulmonary
capillary wedge pressure is greater than or equal to 22mm Hg, 18 out of
43 patients do not have crepitation, pedal oedema, and / or elevated
jugular venous pressure.
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Hence, these physical signs had 58% sensitivity and 100%
specificity for predicting patients with heart failure. But the proportional
pulse pressure correlated well with cardiac index, and when it is less
than 25% proportional pulse pressure had sensitivity of 91% and
specificity of 83% for cardiac index less than 2.2lit/mi n/m2.
 They concluded, “In chronic heart failure patients, the reliance of
physical signs for heart failure might result in inadequate therapy.
Conversely, the reliance of proportional pulse pressure facilitates
decisions in heart failure patients regarding treatment”.
These findings were supported by the results of Shah [12] et  al.,
demonstrated “proportional pulse pressure was the only multivariable
predictor of pulmonary capillary wedge pressure (PCWP) more than 18
mmHg (‘wet patients’) and a cardiac index of less than 2.2 L/min/m2
(‘cold patients’)”.
In a more recent study by Nohria[13] et al., also explained “event-
free survival was significantly lower in the ‘wet and cold’ patients when
compared with the ‘dry and warm’ patients”.
In 2001, Monica R [14]et al., did study on, “Hemodynamic profiles
of advanced heart failure: Association with clinical characteristics and
24
long-term outcomes”. In this study they classified heart failure patients
into four categories according to hemodynamic profiles (symptoms,
physical signs and outcomes) are
1. wet and cold,
2. wet and warm,
3. dry and cold,
4. dry and warm.
They found, “Of the physical examination variables, only a lower
proportional pulse pressure was a significant multivariable predictor of
the wet/cold category”.
In the year of 2009,Miklos de kany[15,37] et all., studied,
“Proportional pulse pressure, a new non invasive parameter  with
prognostic value in advanced heart failure. Therapeutic implications’’.
In this study they enrolled 169 patients with advanced heart failure
(NYHA 3 &4) and assessed their parameters followed by optimization
of treatment. They divided into two groups according to proportional
pulse pressure more than 40% and less than 40%. During follow up they
found  that  1%  increases  in  proportional  pulse  pressure  resulted  in  6%
decrease in mortality.
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From this, they concluded, “In advanced systolic heart failure
treated optimally, proportional pulse pressure is a significant risk
indicator, its higher values relate to a more favourable outcome. When
during treatment optimization proportional pulse pressure increases, we
can count on a favourable long term effect independently from changes
in systolic blood pressure. Proportional pulse pressure involving both
pulse pressure & systolic blood pressure is a simple parameter which
can be used easily in daily clinical practice, follow up, and can help in
treatment optimization”.
Pulse pressure & other clinical parameter in heart failure:
In 1993, Butmansm[17]et  al.,  did  a  study  on  “Bedside
cardiovascular examination in patient with severe chronic heart failure”.
They found the presence of pulmonary crepitation, left ventricular third
heart sound, elevated jugular venous pressure or hepato jugular reflex
will indicate high right heart pressure and low cardiac performance.
Their study yielded a sensitivity of 81% and specificity of 80% and
predictive accuracy of 81% for elevation of pulmonary capillary wedge
pressure greater than or equal to 18 mm hg.
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The Framingham heart study - In 1999, Frankalin et al [19],  did a
study on “Is pulse pressure useful in predicting risk for coronary heart
disease?”. They found, “coronary heart disease risk increased with lower
diastolic blood pressure and any level of systolic blood pressure > or =
120 mm hg in the middle aged and elderly people”. It suggests wide
pulse pressure was an important component of risk factor for coronary
heart disease.
Same year, Micheal et al[20], studied, “Independent prognostic
information provided by sphygmomanometrically determined pulse
pressure and mean arterial pressure in patients with left ventricular
dysfunction”. They found, “a non invasive blood pressure measurement
provides to independent prognostic factors for survival and increased
conduit vessel stiffness as accessed by pulse pressure may contribute to
increased mortality in patient with left ventricular dysfunction,
independent of mean artrial pressure”.
Same year, Chen YT[21] et al , studied, “Risk factors for heart
failure in the elderly: a prospective community- based study.” They
conclude, independent predictors of heart failure are male sex, older age,
diabetes, pulse pressure greater than or equal to 70 mm Hg and body
mass index greater than or equal to 28 kg/m2.
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In  the  year  of  2000,  Fang  J  et  al[22].,  did  a  study  on  “Pulse
pressure: a predictor of cardiovascular mortality among young
normotensive subjects.” They found, Wide pulse pressure is better
predictor of cardiovascular disease events in hypertensive patients
compared to systolic blood pressure, diastolic blood pressure and mean
arterial pressure. In conclusion, “among young subjects, but not older
normotensive persons, at very low risk of cardiovascular disease, a wide
pulse pressure is associated with increased cardiovascular mortality”.
In the same year Viola Vaccarino et al[23],  did a study on “Pulse
Pressure and Risk for Myocardial Infarction and Heart Failure in the
Elderly” also concluded the same.
In the same year, Glynn RJ et al[24], did a study on “Pulse pressure
and mortality in older people.” They conclude, “Pulse pressure appears
to be the best single measure of blood pressure in predicting mortality in
older people and helps explain apprarently discrepant results for low
diastolic blood pressure”.
In  the  year  of  2001,  Colin  J  Petrie  et  al[25].,  did  study  on,  “Low
Pulse Pressure Predicts Mortality In Patients With Left Ventricular
Dysfunction Post Myocardial Infarction, But Only In Those With Signs
28
And Symptoms Of Heart Failure”. In this study, they conclude, “A low
pulse pressure is an independent predictor of mortality in subjects with
depressed left ventricular ejection fraction after  myocardial infarction
and signs and symptoms of heart failure”. These results were supported
by recently published data of a lower pulse pressure as an adverse
predictor in patient with heart failure.
In  the  same  year,  Roland  Asmar  et  al[26]., studied about “Pulse
Pressure” and they conclude, “on the basis of large scale intervention
trials, pulse pressure seems to be an appropriate tool for studies of
clinical pharmacology and therapeutics in the fields of hypertension,
congestive heart failure and other cardiovascular diseases”.
In 2004, Stanley S. Franklin et al[24]., studied, “A low pulse
pressure is an independent predictor of mortality in heart failure”. They
analysed prognostic role of pulse pressure in patients with heart failure.
They concluded, “For any given level of mean arterial pressure, a low
pulse pressure is an independent predictor of cardiovascular death in
patients with heart failure”.
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In the year of 2009, Colin J.Petrie et al [25]., did a study on “Low
pulse pressure is an independent predictor of mortality and morbidity in
non ischaemic, but not in ischaemic advanced heart failure patients”.
From this study they found, “Low pulse pressure is a readily obtainable
risk marker of death in advanced non ischaemic heart failure. Mean
arterial  pressure  remains  an  important  component  of  blood  pressure  in
predicting mortality, especially in those with heart failure of ischaemic
aetiology”.
In the year of 2011, Colin J.Petrie et al [26]., studied, “A low pulse
pressure predicts mortality in subjects with heart failure after an acute
myocardial infarction: a post-hoc analysis of the CAPRICORN study”.
A low pulse pressure is predictive factor for adverse cardiovascular
events in patients with advanced heart failure. They studied “The
prognostic importance of pulse pressure in a group of post-myocardial
infarction patients, with and without signs and symptoms of heart
failure”. From this they concluded “A low pulse pressure is an
independent predictor of mortality in subjects with depressed left
ventricular ejection fraction after a recent myocardial infarction and
evidence of Killip Class II–IV heart failure”.
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In the year of 2015, TakanoriTokitsu et al[31]., did a study on,
“Clinical significance of pulse pressure in patients with coronary artery
disease” This study demonstrated that coronary artery disease patients
with a combination of high pulse pressure with low ankle brachial index
had the highest risk of cardiovascular events, suggesting that combining
ankle brachial index to pulse pressure value could be a more precise
cardiovascular risk predictor in coronary heart disease patients. Ankle
brachial reflex measurement and pulse pressure could be an important
non-invasive parameters of identifying patients with poor prognosis.
This study provides the stronger prognostic significance of pulse
pressure than other blood pressure parameters in coronary heart disease
patients.  In  addition,  combining  pulse  pressure  to  ankle  brachial  reflex
values might further enhance the prediction of cardiovascular risks.
In 2015, Colette E. Jackson, et al[32].,  did  a  study  on  “Differing
prognostic value of pulse pressure in patients with heart failure with
reduced or preserved ejection fraction: results from the MAGGIC
individual patient meta-analysis”.  They conclude “lower pulse pressure
(especially <53 mmHg) was an independent predictor of mortality in
patients with heart failure (HF) with reduced ejection fraction (HF-
REF),  particularly  in  those  with  an  LVEF  <  30%  and  systolic  blood
31
pressure <140 mmHg, but this relationship between pulse pressure and
outcome was not consistently observed among patients with preserved
ejection fraction (HF-PEF)”.
Electrocardiographic changes in heart failure:
In  the  year  of  2005,  Miyoshi  F  et  al., [27] did  a  study  on
“Prolonged QRS duration as a predictor for congestive heart failure”.
They observed QRS duration was significantly prolonged during the
follow up of patients with heart failure (P < 0.05), but did not change in
patients without heart failure.
In the year 2006, Dhingra R et al., [33] did  a  study  on
“Electrocardiographic QRS duration and the risk of congestive heart
failure: the Framingham Heart Study”. They found “longer
electrocardiographic QRS was associated with increased heart failure
risk, consistent with the hypothesis that depolarization delay may
increase heart failure risk”.
In the same, Peter M.okin et al[34].,  did  a  study  on
“Electrocardiographic Strain Pattern and Prediction of New Onset
Congestive Heart Failure in Hypertensive Patients” and they observed
“ECG strain identifies hypertensive patients at increased risk of
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developing heart failure and dying due to heart failure, even in the
setting of aggressive blood pressure lowering”.
In 2005, Adriaan A et al[25]., studied, “Low pulse pressure is
independently related to elevated natriuretic peptides and increased
mortality in advanced chronic heart failure”. In this study, they found,
“Pulse pressure provides a readily available, clinical or bedside
prognostic indicator in advanced heart failure. Low pulse pressure
independently predicts increased mortality. Moreover, low pulse
pressure is independently related to increased natriuretic peptides”.
In the year of 2005,Assmann G et al[26], did a study on
“Importance of arterial pulse pressure as a predictor of coronary heart
disease risk in PROCAM”.  They observed, increases of 10 mmHg in
pulse pressure were associated with an increased risk of coronary heart
disease. Over all , they conclude, “coronary artery disease risk in men
with pulse pressure > or =70 mm hg was more than three times that of
men with pulse pressure <50 mm hg”.
In 2006, Alejandro de la Sierra et al[28]., studied, “ Value of pulse
pressure as a cardiovascular risk marker”. They found, “ Pulse pressure
reduction by antihypertensive treatment in subjects with elevation of this
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parameter (isolated systolic hypertensive) protects against
cardiovascular disease”. The limitation in this study, “the independence
of this protection regarding other blood pressure components or the
existence of clear differences between antihypertensive drug classes on
pulse pressure reduction is still unknown”.
MATERIALS AND
METHODS
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MATERIALS AND METHODS
Place of study:
DEPARTMENT OF GENERAL MEDICINE,
ESIC MEDICAL COLLEGE & PGIMSR,
K.K. NAGAR,
CHENNAI - 78
Study design:
Analytical, longitudinal study
Study period:
12months
Inclusion criteria:
? Patients aged 18 – 75 years with symptoms and signs of heart
failure
Exclusion criteria:
? Age less than 18 years ,
? Age more than 75 years,
? Patient with vavular heart disease, pericardial diseases
? Patients with heart failure secondary to pulmonary disease
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Study Population:
All patients with symptoms and signs of  heart failure admitted to
then department of general medicine, ESIC medical college &PGIMSR,
were enrolled in the study. An informed consent was obtained from the
patients. A detailed history was recorded along with complete clinical
examination as in a proforma. Provisional diagnosis was the one made
and this was subsequently revised after completion of the investigations.
200 patients were screened
170 were enrolled in the study
based on inclusion and
exclusion criteria
150 patients completed
2 followups
143 patients comleted 3
followups
7 Died
20 last follow up in
initial itself
30 patients were not
full filled criteria
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PARAMETERS
1. Jugular venous pressure
2. Peripheral oedema
3. Blood pressure
4. Pulse pressure
5. Proportional pulse pressure
6. Third heart sound
7. Basal crepitation
8. Ejection fraction by ECHO
METHADOLOGY
The study population were assessed with detailed clinical history
and basic clinical examination. Concentrated on presence of elevated
jugular venous pressure, pedal edema, third heart sound, basal
crepitation and blood pressure  measurement according to standard
protocol.
MEASUREMENT OF BLOOD PRESSURE:
Blood pressure was measured by sphygmo-manometry. A aneroid
manometer with cuff of at least 80% the arm circumference in width is
used and inflated around the extended arm .
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American Heart Association Guidelines for Blood Pressure
Measurement:
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Auscultation over the brachial artery provides five phases of
Korotkoff  sounds  as the cuff is deflated:
Phase 1   -  The first appearance of the sounds = SYSTOLIC
BLOOD PRESSURE
Phase 2&3  - The increasing loud sounds
Phase 4  -  Abrupt muffling of the sounds
Phase 5  -  Disappearance of the sounds = DIASTOLIC
BLOOD PRESSURE
From this measurement pulse pressure was calculated by
following formula.
Pulse pressure = Systolic blood pressure – Diastolic blood pressure.
And proportional pulse pressure is calculated by using following
formula.
Proportional pulse pressure =
(In percentage)
Pulse pressure
X 100
Systolic blood pressure
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MEASUREMENT OF ECHOCARDIOGRAPHY
All echocardiographic measurements were obtained with the
patients at rest. The standard echocardiographic examination were
performed by an AcusonSequoiaTM ultrasound machine with a 3.5-MHz
phased-array transducer.
M-mode and two dimensional echocardiography were performed
by experienced cardiologist. And standardized imaging protocol have
been adopted with cross sectional imaging of left ventricle (immediately
distal to the mitral valve tip). M-mode measurements were applied “the
leading edge to leading edge” principle as recommended by the
American Society of Echocardiography(ASE).
Ejection fraction was calculated from the end diastolic volume
and the end systolic volume, using the following formula:
Ejection Fraction  =
End diastolic Volume – End Systolic Volume
End diastolic Volume
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STATISTICAL ANALYSIS
The clinical parameters of heart failure were compared and
analysed using pearson chi square method. The diagnostic accuracy of
all the parameters was then compared and interpreted with reference to
clinical data.
In the present study, the statistical methods were for quantitative
data, descriptive statistics was presented by N, Mean, Standard
Deviation and Range. For qualitative data, frequency count, N and
percentage were put in a tabular manner.
To analyze the data, an appropriate statistical test was applied so
as to find the association between parameters, Chi square test (2x2 cross
tabulation) was used. Screening tests such as Sensitivity, specificity
have been calculated.
All the statistical analysis has been done by using statistical
software  SPSS  (version  16.0).  Other  data,  displayed  by  various  tables
and charts, by using Microsoft excel (windows 8).
* Significant - p < 0.05
** Very significant - p <0.01
*** Highly significant - p < 0.001
OBSERVATION AND
RESULTS
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OBSERVATION AND RESULTS
Table 1:
Group Characteristic in the study people
Character No of Case (n %)
Ejection Fraction ? 30 % 74 (49.3%)
Ejction Fraction 31 % -  40 % 76 (50.7 %)
Male 90 (60 %)
Female 60 (40 %)
NYHA 1 0
NYHA 2 27 (18 %)
NYHA 3 62 (41.3 %)
NYHA 4 61 (40.7 %)
Chest pain 51 (34 %)
Syncope 18 ( 12 %)
Breathlessness on Exertion 133 (88.7 %)
Paroxysmal Nocturnal Dyspnea 51 (34 %)
Orthopnea 71 (47.3 %)
Decreased Urine Output 16 (10.7 %)
Elevated JVP 71 (47.3 %)
Pedal Edema 35 (23.3 %)
Proportional Pulse Pressure ? 25 59
Proportional Pulse Pressure > 25 91
Diabetes mellitus 70 (46.7 %)
Coronary artery disease 114 (76 %)
QRS Widening 86 (57.3 %)
CTR > 55 % 91 (60.7 %)
Pulmonary Edema 86 (57.3 %)
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Table2:
Age distribution in study population:
Age in years No. of patients N %
25--35 2 1%
35--45 18 12%
45--55 27 18%
55--65 49 33%
65--75 43 29%
75--85 11 7%
In this study more no. of patients clumped in age group of 55 – 75
years, explains it is a disease of aged people, though, significant no. of
cases present in younger age group. Mean age is 59years  ± 11years.
Table 3:
Sex distribution of the study population
Study population Male Female
150 90 (60 %) 60 (40%)
Total number of cases – 150
No. of male – 90
No. of female – 60
Male : Female – 3:2
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Fig 1:
Table 4:
Association of Ejection Fraction with Gender:
Sex
Ejection Fraction (%)
Total
?30 % >30 %
Male
45
(60.8%)
45
(59.2%)
90
(60%)
Female
29
(39.2 %)
31
(40.8%)
60
(40%)
Total 74 (100 %) 76(100 %) 150(100%)
 P value 0.841.
Comments:
There is no significant difference in distribution of ejection
fraction among males and females. The pearson chi square value is 0.04
and it is not statistically significant. P value is 0.841.
Sex distribution
male
female
90 (60%)
60 (40 %)
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Table 5:
Distribution of NYHA class in the study people:
Study people NYHA 1 NYHA 2 NYHA 3 NYHA 4
150 0 27 (18 %) 62 (41.3 %) 61 (40.7 %)
Total no. of cases – 150
No. of cases with NYHA 1 – 0
No. of cases with NYHA 2 - 27
No. of cases with NYHA 3 - 62
No. of cases with NYHA 4 - 61
TABLE 6:
Association of  NYHA Class with Ejection Fraction:
NYHA CLASS
Ejection Fraction
Total
? 30 % 31% - 40 %
1 0 0 0
2
0
(0.00%)
27
(35.50%)
27
(18.00%)
3
29
(39.20%)
33
(43.40%)
62
(41.30%)
4
45
(60.80%)
16
(21.10%)
61
(40.70%)
Total
74
(100%)
76
(100%)
150
(100%)
P value <0.001***
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Fig 2:
In this study we found that association between nyha class and
ejection fraction is highly significant. 60 % of the patients with ejection
fraction less than or equal to 30%  comes in nyha class 4 and the same
time only 20 % of other group had nyha class 4. The pearson chi square
value is 41.02 and p value is <0.001 which is highly significant.
Increasing NYHA class associated with lower ejection fraction.
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Fig 3:
This fig. showed the mean value of NYHA class in cases with
ejection fraction less than or equal to 30 % is 3.61 and in cases with
ejection fraction >30% is 2.86.
Table 7:
Correlation between NYHA class and ejection fraction:
NYHA CLASS
N 150
pearson correlation r value -0.56
p value <0.001***
Comments moderate negative correlation
3.61
2.86
0
0.5
1
1.5
2
2.5
3
3.5
4
EF ? 30 % EF 31 % - 40 %
Mean value of NYHA class in the two groups
EF ? 30 %
EF 31 % - 40 %
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Correlating NYHA class and EF has negative correlation that is
one variable increasing means other variable decreasing (i.e NYHA
class increases means EF will decrease vice versa).
Table 8:
Ejection fraction in the study population:
Study population EF 30 % and below EF 31% to 40%
150 patients (100 %) 74 (49.3 %) 76 (50.7 %)
Fig 4:
Ejection fraction obtained from study people were grouped into
two namely, those with ejection fraction < 30 and >30.
No. of cases with ejection fraction < 30 – 74
No. of cases with ejection fraction > 30 – 76
Ejection fraction in the study population
EF 30% AND BELOW
EF 31-40 %
76
74
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Table 9:
Distribution of CAD in the study population:
Coronary artery disease others
No. of cases 114 (76%) 36 (24%)
Fig 5:
In this study population among 150 case 114 cases (76% )
associated with coronary artery disease, it may be aetiology for those
cases.
present
absent
CAD
(76%)
other causes
(24%)
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Table10:
Association between breathlessness on exertion and ejection fraction
Breathlessness on exertion
Ejection Fraction
Total
? 30 % >30%
Present
74 59 133
100% 77.60% 88.70%
Absent
0 17 17
0.00% 22.40% 11.30%
TOTAL
74 76 150
100% 100% 100%
P value <0.001***
All the patients in the study group with ejection fraction up to
30% had breathlessness on exertion and 59% of the other group also had
breathlessness on exertion. The association between ejection fraction
and breathlessness on exertion is highly significant. Pearson chi squre
value is 18.66. P value is < 0.001.
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Fig 6:
Comparison of BOE in two groups:
Table11:
Association between orthopnea and ejection fraction:
Orthopnoea
Ejection Fraction
Total
? 30 % 31-40
Present
47 24 71
(63.50%) (31.60%) (47.30%)
Absent
27 52 79
(36.50%) (68.40%) (52.70%)
Total 74 (100%) 76 (100%) 150 (100%)
P value <0.001***
 In this study, in compare to ejection fraction more than 30 %
,orthopnea more common in ejection fraction less than 30 % patients.
There is a statistically significant association present in between
orthopnea and ejection fraction. Pearson chi square value is 15.33 and P
value is <0.001.
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Fig 7:
Table12:
Association between decreased urine output and ejection fraction:
Decreased urine
output
Ejection fraction
Total
?30% 31%-40%
Present
12 4 16
16.20% 5.30% 10.70%
Absent
62 72 134
83.80% 94.70% 89.30%
Total 74 (100%) 76 (100%) 150 (100%)
P value 0.03*
0%
10%
20%
30%
40%
50%
60%
70%
EF UPTO 30 % EF 31 % - 40 %
36%
68%
64%
32%
orthopnea in the study people
Absent
Present
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In the study population 10 % of the patients only complained of
decreased urine output. And there is statistically significant difference
noted in between the two groups. P value is 0.03.
Table13:
Association between elevated JVP and ejection fraction:
Elevated JVP
EJECTION FRACTION
Total
?30% 31%-40%
Present 54
73.00%
17
22.40%
71
47.30%
Absent 20
27.00%
59
77.60%
79
52.70%
Total
74
100%
76
100%
150
100%
P value <0.001***
Of the 74 cases with ejection fraction less than or equal to30%, 54
patients had elevated JVP. Whereas, of the 76 cases with ejection
fraction  more  than  30  %,  only  17  had  elevated  JVP.  Elevated  JVP  is
highly specific clinical parameter for diagnosing patients with heart
failure with p value  <0.001 which is highly significant.
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Fig 8:
Table 14 :
Association between ejection fraction and systolic blood pressure:
Systolic BP
Ejection fraction
? 30 % 31% - 40 % TOTAL
?90 mmhg 20 (27.02%) 4 (5.26%) 24 (16%)
>90 mmhg 54 (72.97%) 72 (94.74%) 126 (84%)
TOTAL 74 (100%) 76(100%) 150(100%)
P value 0.001***
0%
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40%
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70%
80%
UPTO 30 % 31 % - 40 %
27%
78%73%
22%
ejection fraction
Elevated JVP and ejection fraction
absent
present
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Fig 9:
Among 76 cases of group 2 (EF 31 % - 40%), only 4 (5.2%) cases
had systolic blood pressure less than 90 mm hg in compare to group 1
(EF ? 30%)  where  20  (27%)  cases  had  low systolic  blood  pressure.  It
showed statistically significant association between ejection fraction and
systolic blood pressure. Pearson chi square value is 13.21 and p value is
<0.001.
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Table 15:
Association between ejection fraction and pulse pressure:
Pulse pressure
Ejection fraction
Total
?30% 31% - 40%
? 30 mmhg
63
85.14%
12
15.79%
75
50.00%
>30mmhg
11
14.86%
64
84.21%
75
50.00%
Total
74
100%
76
100%
150
100%
         P value <0.0001***
Fig 10:
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Pulse pressure showed significant association with ejection
fraction. Among group 1 ( EF ?30 %), 85 % of cases had low pulse
pressure and group 2 (EF >30 % ) 85 % of cases had pulse pressure >30
mmhg. Pearson chi square value is 72.11. it is greater than other
parameters. P value is <0.0001.
Table 16:
Association between proportional
pulse pressure and ejection fraction:
Proportional pulse pressure
Ejection fraction
Total
? 30 % 31 % - 40 %
Present
43
58.11%
4
5.26%
47
31.33%
Absent
31
41.89%
72
94.74%
103
68.67%
Total
74
100%
76
100%
150
100%
p value <0.0001***
In this study, there is statistically highly significant association
present between the ejection fraction and proportional pulse pressure.
Chi square value is 48.66 and p value is <0.0001.
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Fig11:
Table 17:
Association between basal crepitation and ejection fraction:
Basal crepitation Ejection fraction Total
?30% 31% - 40%
Present 59
79.73%
43
56.58%
102
68%
Absent 15
19.74%
33
43.42%
48
32%
Total 74
100%
76
100%
150
100%
P value 0.002**
In ejection fraction ? 30 cases, the basal crepitation present in 59
cases (80%)in compare to ejection fraction > 30% cases where 43 cases
(56 %) had basal crepitation. This association is significant with chi
square value 9.23 and p value <0.01.
EF ? 30 % 31 % - 40 % TOTAL
43 4
47
31
72
103
no
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ejection fraction
Proportional pulse pressure VS ejection fraction
PPP ? 25 % > 25 %
58
Fig13:
Table 18:
Association between third heart sound and ejection fraction:
Third heart
sound
ejection fraction
Total
? 30 % 31 % - 40 %
Present
23
31.08%
10
13.16%
33
22.00%
Absent
51
68.92%
66
86.84%
117
78.00%
Total
74
100%
76
100%
150
100%
P value 0.008
EF ? 30% 31 % - 40 % TOTAL
59
43
102
15
33
48
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Basal crepitation
PRESENT ABSENT
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In this study, totally 33 cases among 150 cases showed presence of
third heart sound. The association between ejection fraction and third
heart sound is statistically very significant with p value <0.01. chi
square value is 7.01.
Table 19:
Association between QRS widening and ejection fraction:
QRS WIDENIG
Ejection fraction
Total
?30 % 31% - 40%
Present
54
73.00%
32
42.10%
86
57.30%
Absent
20
27.00%
44
57.90%
64
42.70%
Total
74
(100%)
76
(100%)
150
(100%)
P value <0.0001***
In this study QRS widening significantly associated with ejection
fraction ? 30 %. Chi square value is 14.6. the association is highly
significant with p value <0.0001.
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Fig14:
Table 20:
Association between cardiothoracic ratio and ejection fraction:
Cardio thoracic
ratio
Ejection fraction
Total
?30% 31%- 40%
Present
51
68.90%
40
52.60%
91
60.70%
Absent
23
31.10%
36
47.40%
59
39.30%
Total
74
(100%)
76
(100%)
150
(100%)
P value <0.05*
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In this study we found totally 60% of cases with ejection fraction
<40% showed cardiothoracic ratio >55%. There is statistically
significant association present in between the two. Chi square value
4.168 and p value is <0.05*.
Table 21:
Association between chest pain and ejection fraction:
CHEST PAIN
Ejection Fraction
Total
?30 % >30 %
Present
46
(62.20%)
53
(69.70%)
99
(66.00%)
Absent
28
(37.80%)
23
(30.30%)
51
(34.00%)
Total
74
(100 %)
76
(100 %)
150
(100%)
P value 0.328
In this study the association between chest pain and ejection
fraction is not statistically significant. Chi square value is 0.959. p value
is o.328. About one third patients complained chest pain in both the
groups (in ejection fraction  ? 30%, 62 % and in ejection fraction >
30%,  69%  )  .  And  there  is  no  statistically  significant  difference  in  the
two groups. P value is >0.05.
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Table 22:
Association between syncope and ejection fraction:
Syncope
Ejection Fraction
Total
?30 % 31% -  40%
Present
8
10.80%
10
13.20%
18
12.00%
Absent
66
89.20%
66
86.80%
132
88.00%
Total
74
100%
76
100%
150
100%
P value 0.658
There no significant difference in distribution of syncope in the
two groups. The pearson chi square is 0.196 and P value is 0.658.
Table 23:
Association between PND and ejection fraction:
Paroxysmal
nocturnal
dyspnea
Ejection Fraction
Total
? 30 % 31%-40%
Present
27
36.50%
24
31.60%
51
34.00%
Absent
47
63.50%
52
68.40%
99
66.00%
Total
74
100%
76
100%
150
100%
P value 0.526
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51 patients in the study population complained paroxysmal
nocturnal dyspnea. And tabulation showed the association between
ejection fraction and PND is not statistically significant ( Pearson chi
square value is 0.402). P value is 0.526.
Table 24:
Association between pedal edema and ejection fraction:
Pedal edema
Ejection fraction
Total
? 30 % 31% - 40%
Present
19
25.70%
16
21.10%
35
23.30%
Absent
55
74.30%
60
78.90%
115
76.70%
Total
74
100%
76
100%
150
100%
P value >0.5
Pedal edema not a specific or sensitive parameter for diagnosing
patient with heart failure. And there is no statistically significant
association gained between the ejection fraction and pedal edema. P
value is >0.05.
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Table 25:
Utility of clinical data in detecting patients with low ejection
fraction (<30%) in heart failure:
JVP – jugular venous pressure, BP – blood pressure, PPP – proportional pulse
pressure,
PPV – positive predictive value, NPV – negative predictive value, OR – odds ratio
In this study clinical data were evaluated for detecting low
ejection fraction in heart failure patients. The results were among all the
parameter proportional pulse pressure and systolic blood pressure
showed high specificity (95%)  but both are less common in heart
failure in compare to other parameter ( sensitivity 58%, 27%
respectively, P value - <0.001, OR – 25, 7 respectively). The pulse
pressure had good specificity and sensitivity among all the parameter
(85%, 84% respectively, p - <0.001, OR – 30.55). In this study showed
low sensitivity & specificity for pedal edema( 26%, 59% respectively).
Finding Frequency Sensitivity Specificity PPV NPV OR P
Elevated JVP 71 73% 78% 76% 75% 9.37 <0.001
Pedal edema 35 26% 59% 54% 52% 1.3 >0.5
Systolic BP  ?90 24 27% 95% 83% 57% 6.67 <0.001
Pulse pressure ?30 75 85% 84% 84% 85% 30.55 <0.001
PPP ?25 47 58% 95% 91% 70% 24.97 <0.001
Basal crepitation 102 80% 43% 58% 69% 3.02 <0.001
Third heart sound 33 31% 87% 70% 56% 2.9 <0.01
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Table 26:
Correlation between observed parameter and ejection fraction:
At base line assessment:
Pulse Rate
Systolic
Blood
Pressure
Diastolic
Blood
Pressure
Pulse
Pressure
Proportional
Pulse
Pressure
N 150 150 150 150 150
Pearson
correlation
r value
0.1155 0.6838 0.5415 0.7439 0.6667
p value 0.1592 <0.001*** <0.001*** <0.001*** <0.001***
Commands
Weak
positive
correlation.
moderate
positive
correlation
moderate
positive
correlation
moderate
positive
correlation
moderate
positive
correlation
In this study we evaluate correlation between ejection fraction and
clinical parameters include pulse rate, systolic blood pressure, diastolic
blood pressure, pulse pressure and proportional pulse pressure by using
Pearson correlation coefficient ( r value). There is statistically
significant moderate positive correlation observed between ejection
fraction and pulse pressure, proportional pulse pressure, systolic blood
pressure and diastolic blood pressure with p value <0.001*** which is
highly significant. Among these parameters the positive correlation is
more with pulse pressure (i.e. when pulse pressure decreases ejection
fraction also will decrease and vice versa).
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Fig 16:
Scatter Charts For Correlation Between EF And PP,SBP,PPP:
Fig. showed linear positive correlation between ejection fraction
and pulse pressure at initial assessment.
Fig 17:
Fig. showed linear positive correlation between ejection fraction
and systolic blood pressure at initial assessment.
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Fig18:
Fig. showed linear positive correlation between ejection fraction
and proportional pulse pressure at initial assessment.
Table 27:
During first follow up:
systolic
blood
pressure
diastolic
blood
pressure
pulse
pressure
proportional
pulse
pressure
N 150 150 150 150
pearson
correlation r
value
0.7264 0.6339 0.7631 0.6676
p value <0.001*** <0.001*** <0.001*** <0.001***
Commands
moderate
positive
correlation
moderate
positive
correlation
strong
positive
correlation
moderate
positive
correlation
y = 0.9095x + 6.6785
R² = 0.4445
0
5
10
15
20
25
30
35
40
45
0 10 20 30 40
ej
ec
tio
n 
fr
ac
tio
n
PROPORTIONAL PULSE PRESSURE
Correlation - EF & PPP
EJECTION FRACTION
Linear (EJECTION
FRACTION)
68
After 2 months duration at the time of first follow up, the
correlations between the significant parameters were reassessed. The
results are strong positive correlation for pulse pressure with ejection
fraction was noted. The proportional pulse pressure and systolic blood
pressure had moderate positive correlation.
Fig18:
Fig. showed linear positive correlation between ejection fraction
and pulse pressure at first follow up.
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Fig 19:
Fig. showed linear positive correlation between ejection fraction
and systolic blood pressure at first follow up
Fig 20:
Fig. showed linear positive correlation between ejection fraction
and proportional pulse pressure at first follow up.
y = 0.2163x + 8.1069
R² = 0.5277
0
5
10
15
20
25
30
35
40
45
0 50 100 150 200
ej
ec
tio
n 
fr
ac
tio
n
systolic blood pressure
1st follow up correlation - EF1 & SBP1
EF 1
Linear (EF 1)
y = 0.8729x + 7.7127
R² = 0.4456
0
5
10
15
20
25
30
35
40
45
0 10 20 30 40
ej
ec
tio
n 
fr
ac
tio
n
proportional pulse pressure
1st follow up correlation - EF1 & PPP1
EF 1
Linear (EF 1)
70
Table 28:
During second follow up:
systolic
blood
pressure
diastolic
blood
pressure
pulse
pressure
proportional
pulse
pressure
N 150 150 150 150
pearson
correlation r
value
0.7964 0.6023 0.8213 0.706
p value <0.0001*** <0.0001*** <0.0001*** <0.0001***
Commands
strong
positive
correlation
moderate
positive
correlation
strong
positive
correlation
moderate
positive
correlation
After 2 months duration at the time of second follow up, the
correlations between the significant parameters were reassessed. The
results are strong positive correlation for pulse pressure and systolic
blood pressure with ejection fraction noted. The proportional pulse
pressure had moderate positive correlation.
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Fig 21:
Fig. showed linear positive correlation between ejection fraction
and pulse pressure at second follow up.
Fig 22:
Fig. showed linear positive correlation between ejection fraction
and systolic blood pressure at second follow up.
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Fig 23:
Fig. showed linear positive correlation between ejection fraction
and proportional pulse pressure at second follow up.
Table 29:
During third follow up:
systolic
blood
pressure
diastolic
blood
pressure
pulse
pressure
proportional
pulse
pressure
N 150 150 150 150
pearson
correlation r
value
0.7977 0.6353 0.8219 0.7049
p value <0.001*** <0.001*** <0.001*** <0.001***
Commants
strong
positive
correlation
moderate
positive
correlation
strong
positive
correlation
moderate
positive
correlation
y = 0.8721x + 7.6604
R² = 0.4984
0
5
10
15
20
25
30
35
40
45
0 10 20 30 40 50
ej
ec
tio
n 
fr
ac
tio
n
proportional pulse pressure
2nd follow up correlation - EF2 & PPP2
EF2
Linear (EF2)
73
After  2  months  duration  at  the  third  follow  up,  the  correlations
between the significant parameters were reassessed. The results are
same as second follow up (strong positive correlation for pulse pressure
and systolic blood pressure with ejection fraction) was noted. And the
proportional pulse pressure had moderate positive correlation.
Fig 24:
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THE ANOVA TABLE TEST:
The acceptability of the model from a statistical perspective.
Table 30:
ANOVA(b)
Model Sum of
Squares
df Mean Square F Sig.
1 Regression 1898.332 1 1898.332 118.414 .0001a
Residual 2372.628 148 16.031
Total 4270.96 149
a.Predictors: (Constant), PPP
b. Dependent Variable: EJECTION FRACTION
The Regression row displays information about the variation
accounted for by your model.
The Residual row displays information about the variation that is
not accounted for by your model.
The  significance  value  of  the  F  statistic  is  less  than  0.05,  which
means that the variation explained by the model is not due to chance
While the ANOVA table is a useful test of the model's ability to
explain any variation in the dependent variable, it does not directly
address the strength of that relationship.
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MODEL SUMMARY
Table 31:
Model Summary(b)
Model R R Square
Adjusted R
Square
Std. Error of the
Estimate
1 0.667a 0.444 0.441 4.004
a. Predictors: (Constant), PPP
b. Dependent Variable: EJECTION FRACTION
The model summary table reports the strength of the relationship
between the model and the dependent variable. Its large value indicates
a strong relationship.
R Square, the coefficient of determination, is the squared value of
the multiple correlation coefficient. It shows that about half the variation
in Ejection fraction  is explained by this study model.
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COEFFICIENT OF REGRESSION:
Table 32:
Coefficients(a)
Model
Unstandardized
Coefficients
Standardized Coefficients
95% Confidence
Interval for B
B Std. Error Beta t Sig.
Lower
Bound
Upper
Bound
1 (Constant) 6.679 2.299 … 2.905 0.004 2.136 11.221
PPP 0.91 0.084 0.667 10.882 0.0001 0.744 1.075
a. Dependent Variable: EJECTION FRACTION
This table shows the coefficients of the regression line.
It states that the expected Ejection fraction is equal to 6.679+
0.91* Proportional pulse pressure (the linear regression equation is Y =
a+ bX). If proportional pulse pressure is 25%, the predicted Ejection
fraction would be equal to 6.679 + 0.91*25 calculated as 29.429 that is
ejection fraction nearly 30%, that is predicted from proportional pulse
pressure. It implies that in severe left ventricular dysfunction ( EF<30
%) the possibility of proportional pulse pressure being <25% is high.
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COEFFICIENT OF REGRESSION LINE DURING FOLLOW UP
Table 33:
Coefficients(a)
Model
Unstandardized
Coefficients Standardized Coefficients
95% Confidence Interval
for B
B Std. Error Beta t Sig. LowerBound
Upper
Bound
1 (Constant) 6.679 2.299 2.905 0.004 2.136 11.221
PPP 0.91 0.084 0.667 10.882 0.0001 0.744 1.075
2 (Constant) 7.713 2.216 3.48 0.001 3.334 12.092
PPP_FUP1 0.873 0.08 0.668 10.907 0.0001 0.715 1.031
3 (Constant) 7.66 2.023 3.788 0.001 3.664 11.657
PPP_FUP2 0.872 0.072 0.706 12.126 0.0001 0.736 1.014
4 (Constant) 8.596 2.164 3.972 0.001 4.318 12.874
PPP_FUP3 0.846 0.076 0.682 11.072 0.0001 0.695 0.997
a. Dependent Variable: EJECTION FRACTION
During follow up every 2 months, the reassessed coefficient
regression line showed improvement in proportional pulse pressure
associated with improvement in ejection fraction also by decreasing b
value (0.744 - 1.075,0.715 - 1.031, 0.736 - 1.014,  0.695 - 0.997) in each
follow up.
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Fig 25:
A  histogram  or  P-P  plot  of  the  residuals  helps  to  check  the
assumption of normality of the error term.
The shape of the histogram should approximately follow the
shape of the normal curve. This histogram is acceptably close to the
normal curve.
(A residual is the difference between the observed and model-
predicted values of the  dependent variable.)
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Fig 26:
The P-P plotted residuals should follow the 45-degree line.
Neither the histogram nor the P-P plot indicates that the normality
assumption is violated.
DISCUSSION
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DISSCUSSION
Heart failure remains a common diagnosis for patients presenting
with breathlessness on exertion. Because of high mortality, poor quality
of life heart failure patients requires repeated admissions[1-2].
Heart failure is often diagnosed by detailed clinical history,
careful clinical examination and characteristic findings of electro
cardiogram and chest X-RAY[1-2].
The clinical history alone is insufficient to diagnose heart failure,
only it will give information related to etiology, precipitating factor and
severity of illness.
The symptoms and signs of heart failure can be related to either
decreased cardiac output or fluid retention. In clinical history, absence
of breathlessness on exertion promisingly rules out left ventricular
dysfunction related heart failure.
In examination elevated jugular venous pressure can be a reliable
indicator for increased central venous pressure. Pulmonary crepitation
mostly present in acute and sub-acute heart failure, as times goes on
compensatory mechanism for low cardiac output and water retention
clears crepitation in chronic heart failure[1-2].
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Pedal edema present merely in less than 25% of patient with the
age of less than 60 years.  Hence it is not reliable indicator for heart
failure.
Though lots of clinical studies done over clinical parameter in
heart failure, none of the study says any individual parameter is reliable
one for diagnosing heart failure. Most of the clinical parameter has its
own merits and demerits. Hence multiple clinical parameters have to be
applied for diagnosing heart failure.
In this scenario we rely on sophisticated investigations like echo
cardiogram and level of brain natriuretic peptide to evaluate the heart
failure.
Hence we evaluated the clinical utility of clinical data (elevated
JVP, pedal edema, systolic blood pressure, pulse pressure, proportional
pulse pressure, basal crepitation, and third heart sound) which are non-
invasive and easily applicable even at primary health care sitting for
identifying patients with heart failure. We hope, this information will
help physician in decision making and prognosis assessment in heart
failure patients even at ambulatory level.
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This study population comprised of 150 patients with heart failure
with reduced ejection fraction who satisfied the inclusion and exclusion
criteria. During initial assessment patients were admitted as inpatient
and a detailed clinical history and examination were done followed by
laboratory assessment, electrocardiography and chest X-RAY were done
and echocardiogram was done.Treatment was initiated or continued as
per the standard hospital protocol. The study population was grouped
into two (1) Ejection fraction ? 30%, Ejection fraction, (2) 31% - 40%,
to study the association between clinical parameter and ejection fraction.
Distribution of age group among the study population was
calculated. The results were 49 (33 %) in the age group between 55 – 65
years and 43 (29 %) in the age group between 65 -75 years. In this study
heart failure was more commonly present in patients older than 55
years, may be because of better survival after acute coronary syndrome
and improved management protocol [29].  Louis  et  al[35], studied about
heart failure assessment tool over 372 patients, where the mean age was
53 years ± 13 years. This is in accordance with our study were the mean
age is 59 years ± 11 years.
83
In this study, the male female ratio was approximately 3:2 (Fig:1).
Although there is no sex related difference in the distribution of heart
failure described in literature. The relative incidence is low in women
than in man. Our study also did not show any association between
ejection fraction and gender at p value 0.84 (Table:4).
In this study among 150 patients, nearly 80% of patients
presented with NYHA class 3 and 4 (table 5). The association of NYHA
class with ejection fraction showed statistically significant association at
p value < 0.001 (Table: 6). The mean value of NYHA class in patients
with ejection fraction less than 30% was 3.61, where as in patients with
ejection fraction more than 30 % was 2.86(Fig: 3). When NHYA class
increases ejection fraction decreases. Tansel et al[36], studied about pulse
pressure as a predictor of cardio vascular death, where they showed a
significant association of worsening NHYA class with decreased
ejection fraction, similar to our study. The correlation between NHYA
class and ejection fraction was studied with pearson correlation
coefficient. It showed moderate negative correlation (Table: 7). The r
value  is     -0.56  and  p  value  <  0.001.  It  explained  if   NHYA  class
increases ejection fraction will decrease and vice versa.
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In this study among 150 study population 114 patients had
associated with coronary artery disease (Table: 9). Harrison[1] says in
developed countries coronary artery disease has become the
predominant cause and is responsible for 60-75 % of cases of heart
failure. Similar finding noted in this study also.
Lots of studies explained breathlessness on exertion as the most
common complaint given by patients with heart failure[34-56]. Similarly,
in  our  study  also  showed  the  strong  association  of  breathlessness  on
exertion with ejection fraction at p value <0.001(Table: 10). All the
cases with ? 30 % ejection fraction had breathlessness on exertion.
Orthopnea (taken in account when patient used ? two pillows) was
significantly associated with ejection fraction ? 30 % (p value < 0.001).
Other orthopnea related studies also give similar findings.[41,42]. Mark H
et al, [34,44] studied clinical assessment in heart failure over 194 patients,
they observerd 157 patients among 192 (80%) complained of orthopnea
. In our study 64% of patients with low ejection fraction had orthopnea.
Hence the association between orthopnea and low ejection fraction was
highly significant (table: 11).
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Though, decreased urine out put was infrequent in heart failure it
showed significant association with low ejection fraction with p value
<0.05 (table:12).
A large, analytical study by Mark h dranzeret. al.,[34] showed
elevated jugular venous pressure and third heart sound as prognostic
indicator in asymptomatic patients with heart failure. Elevated jugular
venous pressure was associated with poor outcome in heart failure
patients []. In our study also elevated JVP showed highly significant
association with low ejection fraction, p value is <0.001     (table: 13).
In two studies conducted in heart failure patients to study the
outcome related to systolic blood pressure, the results showed patients
with low systolic blood pressure had poor out comedespite medical
therapy [32,67].  In  this  study,  the  association  between  low systolic  blood
pressure (< 90 mmhg) and low ejection fraction was calculated by chi
square test and the test showed a significant p value <0.001 (table 14).
In  our  study  the  mean  value  of  pulse  pressure  was  around
30mmhg and it was taken as cut off value. 85percent of the patients with
low pulse pressure (?30 mmhg) showed low ejection fraction, same way
patients with >30mmhg pulse pressure had ejection fraction > 30%
(fig 11).
86
The association between pulse pressure and ejection fraction was
highly significant with chi square value of 72 and p value is      < 0.001
(table 15). Many studies were conducted about pulse pressure in heart
failure for example, “ pulse pressure as predictor of cardio vascular
death” [35,57], “pulse pressure and QRS widening as an inexpensive tool
to diagnose heart failure” [38,42], “history and physical examination -
Importance in hear failure” [36,46],  all  the  studies  explained  the
importance and association of pulse pressure in heart failure.
Pulse pressure is a good indicator for heart failure which helps in
risk assessment and prognosis in heart failure. Low pulse pressure is
always associated with poor prognosis in heart failure[30,48,57,68] which is
in accordance with our study results.
The proportional pulse pressure in the study group was assessed
by Pearson chi square test. Proportional pulse pressure ? 25 % was
significantly associated with an ejection fraction ? 30 %. Among our
study population, 47 cases (31%) showed proportional pulse pressure ?
25 % among those 43 (90%) patients had low ejection fraction of ? 30
%. This association is statistically significant with p value < 0.001and
chi square value of 48.66 (table 16).
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A study conducted in Hungary by miklosdekany[37]  about “A non
invasive tool - proportional pulse pressure as prognostic indicator in
advanced systolic left ventricular dysfunction patients and its
therapeutic implication” showed, patients with proportional pulse
pressure ? 40 mmhg had favorable long term prognosis.
A proportional pulse pressure is a noninvasive and inexpensive
risk indicator which can be used in daily clinical practice for risk
assessment in heart failure patients and during follow up for
optimization of treatment[34,64,53]. According to Braunwald’s heart
disease a text book of crdiology[38,72,69], proportional pulse pressure ? 25
% was significantly associated with a low cardiac index of less than 2.2
lit / min/ m2. These results were also noted in our study i.e. Propotional
pulse pressure ?25 % was significantly associated with low ejection
fraction (<30%).
Pulmonary added sounds (crepitation) involving more than 1/3 of
lung base was significantly associated with low ejection fraction. In
group I (Ejection fraction ? 30 %) among 74 patients, 59 patients (80%)
showed basal crepitation.
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As we discussed previously, the study related to “Third heart
sound and elevated jugular veneous pressure as a prognostic indicator in
asymptomatic heart failure”[34,29,59].. Presence of third heart sound in
heart failure was associated with poor prognosis.
In our study also,totally 33 cases among 150 cases showed
presence of third heart sound, in that 23 patients had low ejection
fraction. The association between ejection fraction and third heart sound
is statistically very significant with p value <0.01. Pearson chi square
value was 7.01.
QRS widening (>120ms) is better tool for assessing patient with
heart failure, combined with pulse pressure its clinical utility was
increased[47,56,70]. In our study among 74 patients in group I (EF ? 30 %)
54 cases  (73 %) showed wide QRS complex. The association between
QRS widening and low ejection fraction was statistically highly
significant at p value < 0.001. Chi square value is 14.6 (table 19).
The increased cardio thoracic ratio (> 55 %) was one of the
criteria for diagnosing heart failure [32,40,66]. In our study among 91
patients with increased cardio thoracic ratio nearly 55 % had ejection
fraction ? 30 % and other 45 % had ejection fraction > 30. Though it
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seems to be no much difference in between the two groups, the
association between ejection fraction and increased cardio thoracic ratio
was statistically significant at p value <0.05. Chi square value 4.168
(table: 20).
In our study the association between chest pain and ejection
fraction was not statistically significant. Chi square value was 0.95 and
p value was 0.328. About two third patients complained chest pain in
both the groups (62% in ejection fraction ? 30% and 69% in ejection
fraction >30%). And there was no significant difference in the two
groups.
In this study population syncope was an infrequent finding and
there  was  no  significant  difference  in  distribution  of  syncope  between
the two groups. The pearson chi square was 0.196 and P value was
0.658 (table 22).
In our study, 51 patients in the study population complained
paroxysmal nocturnal dyspnea. The association between ejection
fraction and paroxysmal nocturnal dyspnea was not statistically
significant (table 23). Pearson chi square value was 0.402 and P value
was 0.526.
90
Pedal edema was not a specific or sensitive parameter for
diagnosing patient with heart failure. And there was no statistically
significant association gained between the ejection fraction and pedal
edema. P value was >0.05 (table24).
Utility of clinical data in detecting patients with low ejection
fraction (<30%) in heart failure was calculated using sensitivity,
specificity, positive and negative predictive value. The results of my
study showed that among all the parameters, proportional pulse pressure
and systolic blood pressure showed high specificity (95%)  but both are
less common in heart failure as compared to other parameters, hence
low sensitivity 58%, 27% respectively (P value - <0.001, odds ratio
(OR) – 25, 7 respectively). The pulse pressure had good specificity and
sensitivity among all the parameter (85%, 84% respectively, p - <0.001,
OR – 30.55). This study showed low sensitivity & specificity for pedal
edema( 26%, 59% respectively). Basal crepitation had low specificity
(43%) and good sensitivity (80%). Third heart sound had low sensitivity
( 32%) and good specificity (87%).
Some of the clinical parameters were compared with the study
done by mark h dazner[34] –  the  ESCAPE  trial  “The  value  of
hemodynamics in clinical assessment in advanced heart failure”.
91
Elevated jugular veneous pressure (> 8mmhg) showed 65 % sensitivity
and 64% specificity where as in our study, it was 73% and78%
respectively. The sensitivity and specificity of  pedal edema (?2+) was
66 % and 41 % respectively but in our study it was 59 %, 26%
respectively. The results are in accordance with our study.
In their study pulmonary crepitation showed low sensitivity
(15%) and good specificity. Whereas, in our study the sensitivity and
specificity were 80% and 43% respectively i.e. pulmonary crepitation
had high sensitivity and low specificity comparatively. Third heart
sound showed 62% sensitivity, 32 % specificity, in our study it was 31
% and 87% respectively.
Though, low systolic blood pressure (< 90 mmhg) and
proportional pulse pressure ? 25 mmhg was an infrequent parameter
(sensitivity < 50 %) observed in heart failure patients both parameter
showed good specificity (95 % and 95% respectively) (table - 25).
Hence, the combination of these two parameters will increase the
diagnostic accuracy in patients with heart failure.
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In this study we evaluate the correlation between ejection fraction
and clinical parameters like pulse rate, systolic blood pressure, diastolic
blood pressure, pulse pressure and proportional pulse pressure by using
Pearson correlation coefficient ( r value). And the r value of pulse rate,
systolic blood pressure, diastolic blood pressure, pulse pressure and
proportional pulse pressure were  0.15, 0.68, 0.54, 0.74, and 0.67
respectively.
A statistically significant moderate positive correlation was
observed between ejection fraction and pulse pressure, proportional
pulse pressure, systolic blood pressure and diastolic blood pressure with
p value <0.001*** which is highly significant. And also there was weak
positive correlation observed between ejection fraction and pulse rate.
Among these parameters the positive correlation( r value 0.74, p value
<0.001)  was more with pulse pressure i.e. when pulse pressure
decreases ejection fraction also decreases and vice versa (table 26).
Scatter charts were used to show correlation between parameter
and ejection fraction. Which showed good linear positive correlation for
pulse pressure, systolic blood pressure and proportional pulse pressure
and the coefficient of determination (r2 value) were 0.55, 0.46 and 0.44
respectively ( fig 16, 17 & 18).
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After 2 months duration at the time of first follow up, the
correlations between the significant parameters were reassessed. The
results showed strong positive correlation between pulse pressure and
ejection fraction ( r value 0.76, p value <0.001).
The proportional pulse pressure and systolic blood pressure had
moderate positive correlation (r value 0.72 & 0.66 respectively, p value
<0.001). The diastolic blood pressure also showed moderate positive
correlation ( r value 0.63, p value <0.001) ( table 27). Linear positive
correlation were observed between ejection fraction and clinical
parameters, which was shown in scattered charts ( r2 value 0.58, 0.52 &
0.44 respectively) ( fig 18, 19,  20).
After optimization of treatment at second and third follow up, the
correlations between the significant parameters were reassessed. A
strong positive correlation between pulse pressure and systolic blood
pressure with ejection fraction was noted (r value 0.82 & 0.79
respectively at p value <0.001). The proportional pulse pressure had
moderate positive correlation at r value 0.70 and p value <0.001.
The ANOVA table test was used to test the acceptability of the
model from a statistical perspective[65]. The Regression was 1898. This
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was the information about the variation accounted for by the model. The
Residual was 2372.62. Which was the information about the variation
that is not accounted for by the model (table:30).
The model summary table reports the strength of the relationship
between the model and the dependent variable (table 31). Its large value
(0.44) indicates a strong relationship.R Square (0.44), the coefficient of
determination, is the squared value of the multiple correlation
coefficients. It shows that about half the variation in Ejection fraction
was explained by this study model.
The coefficient of the regression line was used to derive outcome
(Ejection Fraction) from proportional pulse pressure. Table 32 states
that the expected Ejection fraction is equal to a+ b * Proportional pulse
pressure (the linear regression equation is Y = a+ bX (y – Ejection
Fraction, x – proportional pulse pressure)). If proportional pulse
pressure is 25%, the predicted Ejection fraction would be equal to 6.679
+ 0.91*25 calculated as 29.429 that is ejection fraction nearly 30%,
which is predicted from proportional pulse pressure. It implies that in
severe left ventricular dysfunction (Ejection fraction <30 %) the
possibility of proportional pulse pressure being <25% is high vice versa.
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During follow up every 2 months, the reassessed coefficient
regression line showed improvement in proportional pulse pressure also
associated with improvement in ejection fraction. It explained by
decreasing b value (0.744 - 1.075,0.715 - 1.031, 0.736 - 1.014,  0.695 -
0.997) in each follow up (table33). So the proportional pulse pressure
can be used as prognostic indicator for heart failure patients. The similar
results were observed in the study “proportional pulse pressure – a non -
invasive tool to assess the prognosis in advanced heart failure patients”
by Miklosdekany et al[37,45.65].
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To summarize, in our study, the clinical parameter studied in
heart failure patients has resulted in
? Highly significant ( p value <0.001) association observed between
ejection fraction and breathlessness on exertion, orthopnea,
elevated jugular venous pressure, proportional pulse pressure,
systolic blood pressure, pulse pressure, third heart sound and
basal crepitation. The association is more (Pearson chi square
value is 72.11) for pulse pressure as compared to other parameter.
? The specificity for detecting heart failure was more for
proportional pulse pressure and systolic blood pressure ( 95 %
each). The pulse pressure showed good sensitivity and specificity
85%, 84% respectively, p value <0.001, OR – 30.55.
? The correlation of proportional pulse pressure, systolic blood
pressure, and pulse pressure with ejection fraction showed
moderate positive correlation in initial assessment. During follow
up moderate positive correlation  for proportional pulse pressure
was maintained. The correlation of systolic blood pressure and
pulse pressure with ejection fraction was increased to strong
positive correlation. The correlation coefficient regression line
was linear positive for all the three parameters.
? After optimization of treatment, the improvement in proportional
pulse pressure correlates with increased ejection fraction.
CONCLUSION
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CONCLUSION
? The proportional pulse pressure showed moderate positive
correlation with ejection fraction.
? The proportional pulse pressure had good specificity for detecting
patients with heart failure with reduced ejection fraction.
? The proportional pulse pressure was a good prognostic indicator
in heart failure patients, low proportional pulse pressure
associated with poor outcome.
LIMITATIONS
98
LIMITATIONS
? Sample size of the study was small.
? It should be done at community level and compared to control
group (normal population).
?  Period of study should be longer.
FUTURE PERSPECTIVES
99
FUTURE PROSPECTIVE
? A simple non-invasive, bedside clinical tool - Proportional Pulse
Pressure is very helpful to predict the prognosis of heart failure
patients.
? This is more useful when taken to the community level. And it is
most useful in extremely rural (unapproachable rural area) areas
where other investigative tools like echocardiogram are not
available, where the clinician can confidently predict the outcome
of  heart  failure  patients  with  the  simple  tools  of  systolic  blood
pressure, pulse pressure and proportional pulse pressure.
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ANNEXURES
ANNEXURES - I
PROFORMA
“The correlation between proportional pulse pressure and
ejection fraction in heart failure patients”
? Name                                                                     DOA-
? Age                                                                        DOD-
? Sex                                                                         IP no-
? Diagnosis                                                              Address-
? NYHA classification
? Presenting complaints with duration:
?  h/o orthopnea
? h/o weight gain
? Past h/o:
? Family h/0 –
? Drug h/o-
Examination
? General examination-
Jugular venous pressure-
? Vital signs  - Temp
                        Pulse
                        Blood pressure
                       Pulse pressure
                       Proportional pulse pressure
? Systemic examination-
            CVS-
            RS-
            Abdomen-
            CNS-
? INVESTIGATIONS :
1. Basic investigation
2. Electrocardiography
3. Chest x ray
4. ECHO for ejection fraction
• Treatment details..
• Reassessment every 2months
ANNEXURES - II
PATIENT CONSENT FORM
STUDY TITLE:
“The correlation between proportional pulse pressure and ejection
fraction in heart failure patients”
Study center:ESIC Medical College & PGIMSR
Participant Name :
Age:
Sex:        IP No:
I confirm that I have understood the purpose of procedure for the
above study. I have the opportunity to clarify all my queries and doubts and
they have been answered to my satisfaction.
         Investigator explained very well about the procedure and I am made aware
of the safety, advantage and disadvantage of the technique.
            I understand that my participation in the study is purely voluntary and
that I am free to withdraw at anytime without giving any reason.
           I have understood that the investigator, regulatory authorities and the
ethics committee will have access to my health records both in respect to
current study and any further research that may be conducted in relation to it,
even if I decide to withdraw from the study.
I have understood that my identity will not be revealed in anyway and
information released to third parties or published, unless as required under the
law. I agree not to restrict the use of any data or results that arise from the study.
          Without any compulsion I am willing to give consent for the participation
of myself in this study.
Date:                                                             Signature / thumb impression of
patient
Place:
Patient name:
Signature of the investigator:
Name of the investigator:
INFORMATION TO PARTICIPANTS
Investigator: DR.A.P.JANANI
Study centre: ESIC Medical College &PGIMSR, K.K.Nagar, Chennai 78
STUDY TITLE:
“The correlation between proportional pulse pressure and ejection
fraction in heart failure patients”
You are invited to take part in this research study. We have got approval from
the IEC. You are asked to participate because you satisfy the eligibility criteria.
Rights and confidentiality:
       The participation in this study is purely voluntary. You have every right not
to participate in this study. All the data collected in this regard from you will be
kept discretely and your name will not be revealed at any circumstances.
To whom you may contact?
     If you have any doubts and clarification required you can call the doctor ,
JANANI.A.P.at the 7708740509 mobile number at any time.
Signature / Thumb Impression of Patient
Patient Name:
Signature of the Investigator : _______________
Name of the Investigator : _______________
ANNEXURES - II
????? ????
?????:
           “???? ?????? ?????, ??? ????? ???? ????
?????????????????? ?????????? ??? ????????
???”
??? ????: - ESIC????? ???? & PGIMSR
????????? ???? :
??? :
?? / ??? :
???????? ??? ?? ? ???? ??????? ?????? ??? ?
?????????? ???? ??? ?? ??. ?? ????? ???? ????
??????????? ???? ???? ????? ??? ?????? ????
????? ??? ? ??? ?? ??? ???? ?????.
???? ??????? ???? ?? ??? ???? ?? ??????????.
??? ??????? ???? ?? ???? ??????????.
??? ???? , ?? ???? ????? ??, ????????
??????? ??. ??? ???? ? ??,
??? ?????? ? ????? ?????? ???????? ???? ?? ??
????? ? ??? ????????. ??? ???? ??? ??
????????? ???? ?? ???? ??? ? ???????
???? ? ????? ??????? ???????????.
????? ??????? ???? ?? ???? ????? ????,
???????? ??? ???? ???????????? ????? ??.
??????? ? ???????? / ???????????
??? :
??? :
?????? ???? :
???????? :
ANNEXURES – III
CERTIFICATE OF APPROVAL
KEY TO MASTER CHART
NYHA CLASS
CHEYT PAIN
SYNCOPE
BOE Breathlessness on exertion
PND Paroxysmal nocturnal dyspnea
ORTHOPNEA
DECREASED URINE OUTPUT
ELEVATED JVP
PEDAL EDEMA
PR Pulse rate
SBP Systolic Blood Pressure
DBP Diastolic Blood Pressure
PP Pulse Pressure
PPP % Proportional pulse pressure
S3 Third heart sound
SYSTOLIC MURMUR
BASAL CREPITATION
EJECTION FRACTION
NA Sr. sodium
DM Diabetes mellitus
CAD Coronary artery disease
QRS WIDENIG
CTR 55% Cardio thoracic ratio
ANNEXURE - IV
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1 DEVADOSS 60 Female 4 Y N Y N N N Y N 99 90 70 20 22.222 N N Y 30 Y N N Y N 90 70 20 22.222 N Y 30 Y N 96 72 24 25 N N 32 Y N 96 72 24 25 N N 32
2 PREMA 38 Female 4 N N Y N N N N N 90 96 72 24 25 N N Y 32 Y Y Y N N 96 72 24 25 N Y 32 N N 100 70 30 30 N N 35 N N 100 70 30 30 N N 35
3 CHANDRAN 44 Male 4 N N Y N Y Y Y Y 70 80 60 20 25 Y Y N 29 Y N N Y N 80 60 20 25 Y N 29 Y N 86 60 26 30.233 N N 32 N N 86 60 26 30.233 N N 32
4 Balan 45 Male 4 Y N Y Y Y N N Y 72 86 60 26 30.233 N N Y 35 Y Y Y Y Y 90 60 30 33.333 N Y 35 N N 96 60 36 37.5 N Y 37 N N 96 60 36 37.5 N Y 37
5 Murugan 45 Male 4 Y N Y N N N Y N 60 90 70 20 22.222 N N Y 27 Y Y Y Y N 90 70 20 22.222 N Y 27 Y N 96 72 24 25 N N 29 Y N 96 72 24 25 N N 29
6 Mohan 52 Male 4 Y N Y N N N N N 65 88 64 24 27.273 N Y Y 26 Y Y Y N N 90 64 26 28.889 N Y 28 N N 96 64 32 33.333 N Y 31 N N 96 64 32 33.333 N Y 31
7 NAVANEEDHAMMAL67 Female 4 N Y Y Y Y N Y Y 101 106 82 24 22.642 Y N Y 27 Y Y Y Y Y 100 78 22 22 Y Y 27 Y Y 100 70 30 30 N Y 30 Y Y 100 70 30 30 N N 30
8 RAMACHANDRAIYA50 Male 4 Y N Y N N N N N 120 90 66 24 26.667 N N Y 29 Y Y N N N 90 66 24 26.667 N Y 29 N N 96 66 30 31.25 N Y 31 N N 96 66 30 31.25 N Y 31
9 VEERAIYAN 43 Male 3 N N Y Y Y N Y N 89 90 70 20 22.222 Y N N 22 Y N Y Y N 90 70 20 22.222 Y N 22 Y N 96 70 26 27.083 Y N 25 Y N 96 70 26 27.083 Y N 25
10 ANJALAI 66 Female 4 Y N Y Y Y N Y Y 78 78 54 24 30.769 N N Y 35 Y Y Y Y Y 78 54 24 30.769 N Y 35 Y Y 96 64 32 33.333 N N 35 Y Y 96 64 32 33.333 N N 35
11 Vengaiah 65 Male 3 Y Y Y N N N N N 63 120 88 32 26.667 N N Y 35 Y Y Y N N 120 88 32 26.667 N Y 35 N N 126 88 38 30.159 N Y 37 N N 126 88 38 30.159 N Y 37
12 MARIVALEN 35 Male 4 Y N Y N Y N Y N 103 100 76 24 24 N N Y 28 N Y Y Y N 100 76 24 24 N Y 28 Y N 100 72 28 28 N Y 30 N N 100 72 28 28 N Y 30
13 RAVICHANDRAN 75 Male 4 N N Y Y Y N N N 79 64 50 14 21.875 Y Y N 28 Y N N N N 64 50 14 21.875 Y N 25 N N 86 60 26 30.233 N N 27 N N 86 60 26 30.233 N N 27
14 Lakshmi 60 Female 4 N N Y N Y Y Y Y 88 104 72 32 30.769 N N Y 29 Y Y Y Y Y 104 72 32 30.769 N Y 29 Y Y 100 72 28 28 N N 29 Y Y 100 72 28 28 N N 29
15 Sivagangai 60 Female 4 N N Y N N N Y N 98 96 72 24 25 N N Y 21 Y Y Y Y N 90 72 18 20 N Y 21 Y N 90 70 20 22.222 N Y 23 Y N 90 70 20 22.222 N Y 23
16 Agila Devi 47 Female 4 N N Y N N N N N 92 92 72 20 21.739 N Y Y 19 Y Y Y N N 92 72 20 21.739 N Y 19 N N 90 72 18 20 N Y 20 N N 90 72 18 20 N Y 20
17 Mohamed Naniyar 62 Male 4 Y Y Y Y Y Y Y Y 105 110 84 26 23.636 Y N Y 23 Y Y Y Y Y 100 80 20 20 Y Y 25 Y Y 100 72 28 28 Y N 28 Y Y 100 72 28 28 Y N 28
18 Elumalai 62 Male 4 N N Y N N N N N 108 95 60 35 36.842 N N Y 34 Y Y Y N N 90 60 30 33.333 N Y 34 N N 100 66 34 34 N Y 35 N N 100 66 34 34 N Y 35
19 Arumugam 54 Male 4 N N Y N Y N Y N 100 120 88 32 26.667 Y N N 35 Y Y Y Y N 120 88 32 26.667 Y N 35 Y N 120 86 34 28.333 N N 37 Y N 120 86 34 28.333 N N 37
20 Dhanam 56 Female 4 N N Y Y Y Y N Y 89 90 70 20 22.222 N N Y 33 Y Y Y N Y 90 70 20 22.222 N Y 33 N Y 100 76 24 24 N N 35 N Y 100 76 24 24 N N 35
21 Aruldas 33 Male 3 Y N Y N N N N N 102 110 74 36 32.727 N N Y 30 N Y Y N N 100 74 26 26 N Y 30 N N 100 72 28 28 N Y 32 N N 100 72 28 28 N Y 32
22 Unnamalai 72 Female 4 Y Y Y Y Y Y Y Y 88 92 70 22 23.913 N N Y 28 Y N N Y Y 92 70 22 23.913 N Y 28 Y N 96 72 24 25 N Y 30 Y N 96 72 24 25 N Y 30
23 Muthamaal 55 Female 3 N N Y N N N N N 78 96 70 26 27.083 Y Y N 29 Y Y Y N N 96 70 26 27.083 Y N 29 N N 100 70 30 30 N N 32 N N 100 70 30 30 N N 32
24 Kadher Bivi 74 Female 4 Y Y Y Y Y Y Y Y 103 100 70 30 30 N N Y 24 Y N N Y Y 100 70 30 30 N Y 24 Y N 96 70 26 27.083 N Y 26 Y N 96 70 26 27.083 N Y 26
25 Munusamy 63 Male 3 N N Y Y Y N Y N 76 90 68 22 24.444 N N Y 25 N Y Y Y N 90 68 22 24.444 N Y 25 Y N 94 70 24 25.532 N N 27 Y N 94 70 24 25.532 N N 27
26 Chinnaraj 72 Male 4 N Y N N N N N N 110 128 88 40 31.25 N Y Y 35 Y Y Y N N 130 88 42 32.308 N Y 35 N N 136 86 50 36.765 N N 38 N N 136 86 50 36.765 N N 38
27 Mangala lakshmi 75 Female 4 N N Y Y Y N Y N 86 120 86 34 28.333 Y N Y 34 Y Y Y N N 120 86 34 28.333 Y Y 34 N N 120 82 38 31.667 Y Y 35 N N 120 82 38 31.667 Y Y 35
28 Nagalingam 58 Male 4 N N Y Y Y N Y Y 82 90 70 20 22.222 N N Y 34 N Y Y Y Y 90 70 20 22.222 N Y 34 Y Y 96 64 32 33.333 N Y 35 Y Y 96 64 32 33.333 N Y 35
29 Navaneethamal 67 Female 3 Y Y Y Y Y N Y N 92 118 88 30 25.424 Y N N 33 Y Y Y Y N 118 88 30 25.424 Y N 33 Y N 120 82 38 31.667 Y N 35 Y N 120 82 38 31.667 Y N 35
30 Dhamodharan 74 Male 3 N Y Y N N N N N 92 118 86 32 27.119 N N Y 32 Y N N Y N 118 86 32 27.119 N Y 32 Y Y 120 82 38 31.667 N Y 34 N Y 120 82 38 31.667 N N 34
31 Jeyaraman 52 Male 4 N N Y N Y N Y Y 115 90 70 20 22.222 N N Y 30 Y Y Y Y Y 90 70 20 22.222 N Y 30 Y Y 90 70 20 22.222 N Y 32 Y Y 90 70 20 22.222 N Y 32
32 Kaneiyan 65 Male 4 Y N Y N N N N N 96 110 86 24 21.818 N N Y 28 Y Y Y N N 110 80 30 27.273 N Y 30 N N 100 70 30 30 N Y 30 N N 100 70 30 30 N Y 30
33 Nagadas 67 Male 3 Y Y Y N N N N N 60 110 74 36 32.727 Y Y N 34 Y N N N N 130 88 42 32.308 Y N 35 N N 110 74 36 32.727 Y N 35 N N 110 74 36 32.727 Y N 35
34 Ramaiah 65 Male 4 N N Y N Y N Y N 105 110 86 24 21.818 N N Y 25 N Y Y Y N 90 70 20 22.222 N Y 27 Y N 110 86 24 21.818 N Y 29 Y N 110 86 24 21.818 N N 29
35 Veeraiah 43 Male 4 Y N Y Y Y Y Y Y 66 92 70 22 23.913 N N Y 26 Y N N Y Y 100 70 30 30 N Y 29 Y Y 92 70 22 23.913 N Y 26 Y Y 92 70 22 23.913 N N 26
36 Krishnaveni 66 Male 3 Y N Y Y Y Y Y Y 76 96 72 24 25 N Y Y 27 N Y Y Y Y 100 70 30 30 N Y 30 N Y 96 72 24 25 N Y 27 N Y 96 72 24 25 N Y 27
37 Jyotheeshwari 65 Female 4 Y N Y Y Y N N N 74 116 88 28 24.138 Y N Y 35 N Y Y N N 110 80 30 27.273 Y Y 36 N N 116 88 28 24.138 Y Y 35 N N 116 88 28 24.138 Y N 35
38 Kaveri 63 Female 4 N N Y N N N N N 96 110 80 30 27.273 N N Y 30 N Y Y N N 100 70 30 30 N Y 30 N N 110 80 30 27.273 N Y 30 N N 110 80 30 27.273 N Y 30
39 Pappa 60 Female 3 N N Y Y Y N Y N 85 128 88 40 31.25 Y N N 33 Y Y N Y N 128 88 40 31.25 Y N 35 Y N 128 88 40 31.25 Y N 33 Y Y 128 88 40 31.25 Y N 33
40 Jeyaraman 55 Male 4 N N Y N N N N N 84 120 88 32 26.667 N N Y 32 N Y Y Y N 128 88 40 31.25 N Y 35 Y N 120 88 32 26.667 N Y 32 Y N 120 88 32 26.667 N Y 32
41 Srinathan 46 Male 3 N N Y Y Y Y Y Y 80 112 78 34 30.357 N N Y 31 N Y Y Y Y 130 88 42 32.308 N Y 34 Y Y 112 78 34 30.357 N Y 31 Y Y 112 78 34 30.357 N Y 31
42 Rajathi 68 Female 3 N N Y N N N Y N 109 100 74 26 26 N N Y 26 N Y Y Y N 100 70 30 30 N Y 30 Y N 100 74 26 26 N Y 28 Y N 100 74 26 26 N Y 28
43 Chandra 52 Female 3 Y N Y N Y N Y N 90 100 70 30 30 Y Y N 27 N Y Y Y N 100 70 30 30 Y N 29 Y N 100 70 30 30 Y N 27 Y N 100 70 30 30 Y N 27
44 Mary Kamalam 65 Female 4 N N Y N N N N N 76 102 76 26 25.49 N N Y 29 Y N N N N 100 70 30 30 N Y 30 N N 102 76 26 25.49 N Y 29 N N 102 76 26 25.49 N N 29
45 Subraiya bu 72 Male 3 N N Y Y Y N Y N 60 90 70 20 22.222 N N Y 22 Y N N Y N 90 70 20 22.222 N Y 22 Y N 86 68 18 20.93 N Y 19 Y N 86 68 18 20.93 N Y 19
46 Latha 52 Female 4 Y Y Y N Y N Y N 64 96 72 24 25 N Y Y 24 Y N N Y N 100 70 30 30 N Y 25 Y N 96 72 24 25 N Y 24 Y Y 96 72 24 25 N Y 24
47 Papathi 64 Female 4 Y N Y Y Y Y Y Y 119 110 84 26 23.636 Y N Y 23 Y N N Y Y 110 82 28 25.455 Y Y 26 N N 110 84 26 23.636 Y Y 25 N N 110 84 26 23.636 Y N 25
48 Kandhan 64 Male 3 N N Y Y Y N Y N 98 128 88 40 31.25 N N Y 29 N Y Y Y N 128 88 40 31.25 N Y 30 Y N 100 70 30 30 N Y 27 Y N 100 70 30 30 N Y 27
49 Sukumaran 48 Male 4 N N Y Y Y N Y Y 79 90 70 20 22.222 Y N N 27 N Y Y Y Y 90 70 20 22.222 Y N 25 Y Y 92 70 22 23.913 Y N 27 Y N 92 70 22 23.913 Y N 27
50 Jeyaraman 64 Male 4 N N Y Y Y N N Y 80 96 72 24 25 N N Y 35 Y N N N Y 90 70 20 22.222 N Y 30 N Y 110 72 38 34.545 N Y 35 N Y 110 72 38 34.545 N Y 35
51 Saratha 60 Female 3 Y N Y Y Y N Y N 98 106 80 26 24.528 N N Y 30 Y N N Y N 106 80 26 24.528 N Y 30 N N 100 78 22 22 N Y 27 N N 100 78 22 22 N N 27
52 Ismail 62 Male 4 Y N Y Y Y N N N 65 104 80 24 23.077 N N Y 29 Y N N N N 104 80 24 23.077 N Y 29 N N 96 74 22 22.917 N Y 27 N N 96 74 22 22.917 N Y 27
53 Mohan 64 Male 3 Y N Y N N N Y N 85 100 78 22 22 Y Y N 24 N Y Y N N 100 78 22 22 Y N 24 N N 86 68 18 20.93 Y N 22 NN N 86 68 18 20.93 Y N 22
54 Inderani 60 Female 3 N Y Y N Y N Y Y 84 102 78 24 23.529 N N Y 25 Y Y N Y Y 102 78 24 23.529 N Y 25 Y Y 94 72 22 23.404 N Y 24 N Y 94 72 22 23.404 N Y 24
55 Rajasekaran 64 Male 4 N N Y N N N N N 100 98 72 26 26.531 N N Y 30 Y Y N N N 98 72 26 26.531 N Y 30 N N 92 72 20 21.739 N Y 27 N N 92 72 20 21.739 N Y 27
56 Ramalingam 76 Male 4 N N Y N Y N Y N 78 94 72 22 23.404 N Y Y 30 Y N N Y N 94 72 22 23.404 N Y 30 Y N 90 72 18 20 N Y 28 N N 90 72 18 20 N Y 28
57 Devaraj 70 Male 4 N N Y N N N N N 96 128 88 40 31.25 Y N Y 30 Y Y Y N N 128 88 40 31.25 Y Y 30 N N 110 88 22 20 Y Y 27 N N 110 88 22 20 Y N 27
58 Mohamed Shoieb 66 Male 3 N N Y Y Y N Y N 72 98 72 26 26.531 N N Y 34 N Y Y Y N 98 72 26 26.531 N Y 34 Y N 118 86 32 27.119 N Y 33 Y Y 118 86 32 27.119 N Y 33
59 Muniyandi 52 Male 4 N Y Y Y Y Y Y Y 74 120 88 32 26.667 Y N N 32 Y N N N N 110 88 22 20 Y N 32 N N 106 80 26 24.528 Y N 30 death
60 Kuppammal 74 Female 3 Y Y Y Y Y N Y N 104 100 72 28 28 N N Y 32 Y Y Y Y N 100 72 28 28 N Y 32 Y N 100 72 28 28 N Y 32 death
61 Francis 65 Male 3 N N Y N Y N Y N 66 90 70 20 22.222 N N Y 18 Y N N Y N 90 70 20 22.222 N Y 18 Y Y 86 70 16 18.605 N Y 18 death
62 Murthy 63 Male 3 N N Y N N N Y N 68 102 78 24 23.529 N N Y 21 Y Y Y Y N 102 78 24 23.529 N Y 21 N N 90 72 18 20 N Y 21 death
63 Rajendran 52 Male 4 N N Y N N N Y Y 88 90 70 20 22.222 Y Y N 25 Y Y Y Y Y 90 70 20 22.222 Y N 25 Y Y 90 70 20 22.222 Y N 25 death
64 Ranganayagi 58 Female 4 Y N Y N Y N Y N 91 100 70 30 30 N N Y 29 Y Y Y Y N 100 70 30 30 N Y 29 Y N 100 70 30 30 N Y 29 death
65 Meena 45 Female 4 Y N Y N N N Y N 104 92 70 22 23.913 N N Y 27 Y Y Y N N 92 70 22 23.913 N Y 27 N N 92 70 22 23.913 N Y 27 death
66 Angamuthu 67 Male 3 N N Y Y Y N Y N 98 110 84 26 23.636 N Y Y 29 Y Y N Y Y 110 84 26 23.636 N Y 29 Y Y 106 84 22 20.755 N Y 29 Y Y 106 84 22 20.755 N N 29
67 Navaneethamal 67 Female 3 N N Y N Y N N N 60 92 70 22 23.913 Y N Y 29 Y N Y N N 92 70 22 23.913 Y Y 29 N N 92 70 22 23.913 Y Y 29 N N 92 70 22 23.913 Y Y 29
68 Jeyaraman 54 Male 4 Y N Y Y Y Y Y Y 68 92 70 22 23.913 N N Y 25 Y Y Y Y Y 92 70 22 23.913 N Y 28 N N 92 70 22 23.913 N Y 28 N N 92 70 22 23.913 N N 28
69 Kuppusamy 77 Male 4 Y N Y N N N Y N 63 90 70 20 22.222 Y N N 26 Y Y Y Y N 90 70 20 22.222 Y N 26 Y N 90 70 20 22.222 Y N 26 Y N 90 70 20 22.222 Y N 26
70 Kathavarayan 52 Male 3 N N Y N Y N Y N 70 96 72 24 25 N N Y 26 N Y Y Y N 96 72 24 25 N Y 26 Y N 96 72 24 25 N Y 26 Y N 96 72 24 25 N Y 26
71 Badma 75 Female 3 N N Y N N N N N 76 110 70 40 36.364 N N Y 35 Y N N N N 110 70 40 36.364 N Y 35 N N 110 70 40 36.364 N Y 35 N N 110 70 40 36.364 N Y 35
72 Inderani 60 Female 4 N N Y N Y N N N 72 98 72 26 26.531 N N Y 30 Y Y Y N N 98 72 26 26.531 N Y 30 N N 98 72 26 26.531 N Y 30 N N 98 72 26 26.531 N Y 30
73 Duraisamy 68 Male 4 N N Y N Y N N N 80 128 88 40 31.25 Y Y N 30 Y Y Y N N 128 88 40 31.25 Y N 30 N N 102 76 26 25.49 Y N 30 N N 102 76 26 25.49 Y N 30
74 Kathirvel 65 Male 4 N N Y N N N N N 89 120 88 32 26.667 N N Y 31 Y Y Y Y N 120 88 32 26.667 N Y 31 Y N 106 82 24 22.642 N Y 31 Y N 106 82 24 22.642 N N 31
75 Selvamani 50 Male 3 N Y Y N N N N N 84 98 72 26 26.531 N N Y 34 Y Y Y N N 98 72 26 26.531 N Y 32 N N 98 72 26 26.531 N Y 32 N N 98 72 26 26.531 N Y 32
76 Ramalingam 75 Male 4 N N Y N Y N Y N 82 90 70 20 22.222 N Y Y 26 Y Y Y Y N 90 70 20 22.222 N Y 26 Y N 90 70 20 22.222 N Y 26 Y N 90 70 20 22.222 N N 27
77 Sivashankar 65 Male 4 Y N Y N Y N Y Y 96 102 78 24 23.529 Y N Y 26 Y Y Y Y Y 96 72 24 25 Y Y 26 Y Y 96 72 24 25 Y Y 26 Y Y 96 72 24 25 Y Y 26
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78 Rajan 40 Male 3 Y N Y N Y N Y N 60 96 72 24 25 N N Y 27 Y Y Y Y N 96 72 24 25 N Y 27 N N 96 72 24 25 N Y 27 N N 96 72 24 25 N Y 27
79 Prema 55 Female 4 N N Y N N N Y N 80 90 70 20 22.222 Y N N 24 N Y Y Y N 90 70 20 22.222 Y N 24 Y N 90 70 20 22.222 Y N 24 Y N 90 70 20 22.222 Y N 24
80 Nagalingam 58 Male 4 N N Y N Y N N N 82 98 72 26 26.531 N N Y 30 Y N N N N 98 72 26 26.531 N Y 30 N N 98 72 26 26.531 N Y 30 N N 98 72 26 26.531 N Y 30
81 Ismail 61 Male 3 Y N Y N N N N N 78 128 88 40 31.25 N N Y 30 Y Y Y N N 128 88 40 31.25 N Y 30 N N 128 88 40 31.25 N Y 30 N N 128 88 40 31.25 N N 30
82 Manimegalai 63 Female 4 N N Y Y Y Y N Y 114 100 70 30 30 N N Y 34 Y N N N Y 100 70 30 30 N Y 34 N Y 100 70 30 30 N Y 34 N Y 100 70 30 30 N Y 34
83 Srinivasan 70 Male 4 N N Y N N N Y N 98 96 72 24 25 Y Y N 27 N Y Y Y N 96 72 24 25 Y N 27 N N 96 72 24 25 Y N 27 N N 96 72 24 25 Y N 27
84 Yesupudhan 70 Male 3 N N Y Y Y Y Y Y 65 98 72 26 26.531 N N Y 29 Y Y Y Y Y 98 72 26 26.531 N Y 29 Y Y 96 72 24 25 N Y 29 Y Y 96 72 24 25 N Y 29
85 Mariammal 60 Female 4 N N Y Y N N Y N 68 110 84 26 23.636 N N Y 29 Y Y Y Y N 100 74 26 26 N Y 29 Y N 96 74 22 22.917 N Y 29 Y N 96 74 22 22.917 N Y 29
86 Anjalaachi 65 Female 4 N N Y Y Y N Y N 72 96 72 24 25 N Y Y 28 N Y Y N N 96 72 24 25 N Y 28 N N 96 72 24 25 N Y 28 N N 96 72 24 25 N Y 28
87 Haji Mohamed 60 Male 3 N Y Y N Y N Y N 78 96 72 24 25 Y N Y 26 Y Y Y Y Y 96 72 24 25 Y Y 26 Y Y 96 72 24 25 Y Y 26 Y Y 96 72 24 25 Y Y 26
88 Balakrishnan 56 Male 4 N N Y N N N Y N 70 102 78 24 23.529 N N Y 24 Y N N Y N 94 70 24 25.532 N Y 26 Y N 94 70 24 25.532 N Y 26 Y N 94 70 24 25.532 N N 26
89 Pappa 60 Female 3 Y N Y N Y N Y N 117 96 72 24 25 Y N N 28 Y Y Y Y N 96 72 24 25 Y N 28 Y Y 96 72 24 25 Y N 28 Y Y 96 72 24 25 Y N 28
90 Viji 40 Female 4 N N Y N N N Y N 70 110 84 26 23.636 N N Y 24 Y Y Y Y N 110 84 26 23.636 N Y 24 N N 96 70 26 27.083 N Y 24 N N 96 70 26 27.083 N Y 24
91 Balagurusamy 71 Male 3 Y N Y N N N Y N 79 90 70 20 22.222 N N Y 26 Y N N Y N 90 70 20 22.222 N Y 26 Y N 90 70 20 22.222 N Y 26 Y N 90 70 20 22.222 N Y 26
92 Murugan 75 Male 4 N N Y Y Y N N N 90 92 70 22 23.913 N N Y 29 N Y Y N N 92 70 22 23.913 N Y 29 N N 92 70 22 23.913 N Y 29 N N 92 70 22 23.913 N Y 29
93 Mariammal 71 Female 3 N N Y Y Y N Y Y 86 90 68 22 24.444 Y Y N 29 Y N N Y Y 90 68 22 24.444 Y N 29 Y Y 90 68 22 24.444 Y N 29 Y Y 90 68 22 24.444 Y N 29
94 Annamary 65 Female 3 N N Y N N N N N 84 100 76 24 24 N N Y 27 N Y Y N N 100 76 24 24 N Y 27 N N 100 76 24 24 N Y 27 N N 100 76 24 24 N N 27
95 Chellaiah pillai 73 Male 4 N N Y Y Y Y Y Y 82 90 70 20 22.222 N N Y 21 N Y Y N Y 90 70 20 22.222 N Y 21 N Y 90 70 20 22.222 N Y 21 N Y 90 70 20 22.222 N Y 23
96 Khader beeve 75 Female 3 N Y Y Y Y Y Y Y 112 94 72 22 23.404 N Y Y 25 N Y Y Y Y 94 72 22 23.404 N Y 25 Y Y 94 72 22 23.404 N Y 25 Y Y 94 72 22 23.404 N Y 25
97 Karupaiah 72 Male 3 N N Y Y Y N Y N 78 120 88 32 26.667 Y N Y 29 Y Y N Y N 120 88 32 26.667 Y Y 29 Y N 108 78 30 27.778 Y Y 29 Y N 108 78 30 27.778 Y N 29
98 Subburayan 72 Male 3 Y N Y Y Y N N N 79 100 74 26 26 N N Y 29 N Y Y N N 100 74 26 26 N Y 29 N N 100 74 26 26 N Y 29 N N 100 74 26 26 N Y 29
99 Shenbagam 55 Female 3 N N Y Y Y N Y N 105 90 68 22 24.444 Y N N 27 N Y Y Y N 90 68 22 24.444 Y N 27 Y Y 90 68 22 24.444 Y N 27 Y Y 90 68 22 24.444 Y N 27
100 Gowrishankar 65 Male 4 N N Y N N N N N 76 98 72 26 26.531 N N Y 35 N Y Y N N 98 72 26 26.531 N Y 35 N N 98 72 26 26.531 N Y 35 N N 98 72 26 26.531 N Y 35
101 Murthy 64 Male 2 N N Y N N N N N 74 112 78 34 30.357 N N Y 36 N Y Y N N 112 78 34 30.357 N Y 36 N N 112 78 34 30.357 N Y 36 N N 112 78 34 30.357 N Y 36
102 Duraisamy 61 Male 2 N N Y Y Y N Y Y 80 114 80 34 29.825 N N Y 33 Y N N Y Y 114 80 34 29.825 N Y 33 Y Y 118 80 38 32.203 N Y 35 Y Y 118 80 38 32.203 N Y 35
103 Kannan 65 Male 3 Y N Y N N N N N 100 140 90 50 35.714 Y Y N 38 Y N N N Y 140 90 50 35.714 Y N 38 N Y 140 90 50 35.714 Y N 38 N Y 140 90 50 35.714 Y N 38
104 kuppan 40 Male 3 N N Y Y Y N N N 86 140 100 40 28.571 N N Y 39 Y N N N N 140 100 40 28.571 N Y 39 N N 140 100 40 28.571 N Y 39 N N 140 100 40 28.571 N N 39
105 Mani 56 Male 3 Y N Y N N N N N 86 150 110 40 26.667 N N Y 37 Y N N N N 150 110 40 26.667 N Y 37 N N 140 86 54 38.571 N Y 37 N N 140 86 54 38.571 N Y 37
106 Thirunavukarasu 42 Male 3 Y N Y Y N N N N 76 138 90 48 34.783 N Y Y 38 N Y Y N N 138 90 48 34.783 N Y 38 N N 138 90 48 34.783 N Y 38 N N 138 90 48 34.783 N Y 38
107 Arivalagzhan 63 Male 3 Y N N N N N N N 108 120 88 32 26.667 Y N Y 36 N Y Y N N 120 88 32 26.667 Y Y 36 N N 120 88 32 26.667 Y Y 36 N N 120 88 32 26.667 Y N 36
108 Pachiammal 83 Female 2 N N Y Y Y N Y Y 84 112 78 34 30.357 N N Y 35 Y N N Y Y 112 78 34 30.357 N Y 35 Y Y 118 80 38 32.203 N Y 38 Y Y 118 80 38 32.203 N Y 38
109 Badma 55 Female 3 N N Y Y Y N N Y 71 128 88 40 31.25 Y N N 39 Y N N N Y 128 88 40 31.25 Y N 39 N Y 128 88 40 31.25 Y N 39 N Y 128 88 40 31.25 Y N 39
110 Ramalingam 59 Male 3 N N Y N N N N N 86 120 80 40 33.333 N N Y 38 Y N N N N 120 80 40 33.333 N Y 38 N N 120 80 40 33.333 N Y 38 N N 120 80 40 33.333 N Y 38
111 Selvanathan 39 Male 3 N N Y Y Y N Y N 118 110 86 24 21.818 N N Y 36 N Y Y Y N 110 86 24 21.818 N Y 36 Y N 110 86 24 21.818 N Y 36 Y N 110 86 24 21.818 N Y 36
112 Kalyani 48 Female 3 Y N Y N N N N N 98 118 80 38 32.203 N N Y 36 Y Y N N N 118 80 38 32.203 N Y 36 N N 118 80 38 32.203 N Y 36 N N 118 80 38 32.203 N N 36
113 Nagaraj 42 Male 3 N Y Y N N N N N 70 116 86 30 25.862 N Y N 35 Y Y N N N 116 86 30 25.862 N N 35 N N 116 86 30 25.862 N N 35 N N 116 86 30 25.862 N N 35
114 Velammal 65 Female 3 Y N Y N N N Y N 67 112 80 32 28.571 N N Y 34 Y N N Y N 112 80 32 28.571 N Y 34 Y N 112 80 32 28.571 N Y 34 Y N 112 80 32 28.571 N Y 34
115 Vasantha 63 Female 3 N N Y N N N N N 64 114 80 34 29.825 N N Y 34 Y Y Y Y N 114 80 34 29.825 N Y 34 Y N 114 80 34 29.825 N Y 34 Y N 114 80 34 29.825 N Y 34
116 Ravi 51 Male 3 Y N Y N N N N N 112 112 80 32 28.571 N Y Y 34 N Y Y N Y 112 80 32 28.571 N Y 34 N N 112 80 32 28.571 N Y 34 N N 112 80 32 28.571 N Y 34
117 Pushpa 35 Female 2 Y N Y N N N N N 85 112 78 34 30.357 N N Y 36 Y N N N N 112 78 34 30.357 N Y 36 N N 112 78 34 30.357 N Y 36 N N 112 78 34 30.357 N Y 36
118 Prasanna 47 Male 2 N N Y N N N N N 68 140 90 50 35.714 N N Y 35 Y Y Y N N 140 90 50 35.714 N Y 35 N N 140 90 50 35.714 N Y 35 N N 140 90 50 35.714 N Y 35
119 Jaya 53 Female 2 N N Y N N N Y Y 88 140 100 40 28.571 N N N 38 Y N N Y Y 140 100 40 28.571 N N 38 N Y 140 100 40 28.571 N N 38 N Y 140 100 40 28.571 N N 38
120 Shanthi 56 Female 2 N N Y N N N N N 120 150 110 40 26.667 N N Y 37 Y N N N N 150 110 40 26.667 N Y 37 N N 150 110 40 26.667 N Y 37 N N 150 110 40 26.667 N Y 37
121 Vasugi 45 Female 2 N N Y Y Y N N Y 89 138 90 48 34.783 N N N 37 Y N N N N 138 90 48 34.783 N N 37 N N 138 90 48 34.783 N N 39 N N 138 90 48 34.783 N N 39
122 Veerammal 71 Female 3 N N N N N N N N 84 120 88 32 26.667 N N N 38 Y N N N N 120 88 32 26.667 N N 38 N N 120 88 32 26.667 N N 38 N N 120 88 32 26.667 N N 38
123 Meena 29 Female 3 Y N Y Y Y N N Y 74 112 78 34 30.357 N Y Y 38 Y N N N Y 112 78 34 30.357 N Y 38 N Y 112 78 34 30.357 N Y 38 N N 112 78 34 30.357 N N 38
124 Prabhakaran 38 Female 3 N N N N N N N N 115 128 88 40 31.25 N N N 36 Y Y N N N 128 88 40 31.25 N N 36 N N 128 88 40 31.25 N N 36 N N 128 88 40 31.25 N N 36
125 Selvaraj 68 Male 3 N N Y N N N Y N 88 112 80 32 28.571 N N Y 36 Y N Y Y N 112 80 32 28.571 N Y 36 N Y 112 80 32 28.571 N Y 36 N Y 112 80 32 28.571 N N 36
126 Raja 60 Male 3 N N Y Y Y N N N 83 128 88 40 31.25 N Y N 39 Y Y Y N N 128 88 40 31.25 N N 39 N N 128 88 40 31.25 N N 39 N N 128 88 40 31.25 N N 39
127 Munuswamy 58 Male 3 N N Y N N N N N 115 114 80 34 29.825 N N N 39 Y N N N N 114 80 34 29.825 N N 39 N N 114 80 34 29.825 N N 39 N N 114 80 34 29.825 N N 39
128 Raman 60 Male 2 Y N N N N N N N 79 114 82 32 28.07 N N N 39 N N N N N 114 82 32 28.07 N N 39 N N 114 82 32 28.07 N N 39 N N 114 82 32 28.07 N N 39
129 Thirupathi 64 Male 2 N N Y N N N N N 76 140 90 50 35.714 N N N 39 Y N Y N N 140 90 50 35.714 N N 39 N N 140 90 50 35.714 N N 39 N N 140 90 50 35.714 N N 39
130 Nandhakumar 62 Male 3 Y N Y N N N N N 78 140 100 40 28.571 N N Y 38 Y N Y Y N 140 100 40 28.571 N Y 38 N N 140 100 40 28.571 N Y 38 N N 140 100 40 28.571 N N 38
131 Kumar 42 Male 2 N N Y N N N N N 104 150 110 40 26.667 N N N 38 Y N N N N 150 110 40 26.667 N N 38 N N 150 110 40 26.667 N N 40 N N 150 110 40 26.667 N N 40
132 Manjura beevi 49 Female 2 N N N N N N N N 70 138 90 48 34.783 N N N 39 Y N Y N Y 138 90 48 34.783 N N 39 N Y 138 90 48 34.783 N N 39 N Y 138 90 48 34.783 N N 39
133 Surya begam 55 Female 2 N N Y Y Y N N Y 71 120 88 32 26.667 N Y N 39 Y N N N Y 120 88 32 26.667 N N 39 N Y 120 88 32 26.667 N N 39 N N 120 88 32 26.667 N N 39
134 Saraswathi 70 Female 3 Y N N N N N N N 114 112 78 34 30.357 N N N 35 Y N Y N N 112 78 34 30.357 N N 35 N N 112 78 34 30.357 N N 35 N N 112 78 34 30.357 N N 35
135 Saratha 40 Female 2 Y N Y N N N N N 96 128 88 40 31.25 N N N 35 Y N N N N 128 88 40 31.25 N N 35 N N 128 88 40 31.25 N N 35 N N 128 88 40 31.25 N N 35
136 Latha 59 Female 2 N N N N N N N N 117 116 80 36 31.034 N Y Y 35 Y N Y N N 116 80 36 31.034 N Y 35 N N 116 80 36 31.034 N Y 35 N N 116 80 36 31.034 N Y 35
137 Ellamma 65 Female 2 N N N N N N N N 90 114 80 34 29.825 N N N 34 N N N N N 114 80 34 29.825 N N 34 N N 114 80 34 29.825 N N 36 N N 114 80 34 29.825 N N 36
138 Radhakrishnan 75 Male 2 N N Y N N N Y N 88 112 80 32 28.571 N N N 34 Y N N Y N 112 80 32 28.571 N N 34 N N 112 80 32 28.571 N N 35 N N 112 80 32 28.571 N N 35
139 Syed mohammed 66 Male 2 N N N N N N N N 82 116 80 36 31.034 N N N 38 Y N Y N N 116 80 36 31.034 N N 38 N N 116 80 36 31.034 N N 38 N N 116 80 36 31.034 N N 38
140 Krishnan 42 Male 2 N N Y N N N N N 79 138 100 38 27.536 N N N 39 Y N N N N 138 100 38 27.536 N N 39 N N 138 100 38 27.536 N N 39 N N 138 100 38 27.536 N N 39
141 Vijaya 39 Female 2 N N N N N N N N 113 116 76 40 34.483 N N N 39 N N Y N N 116 76 40 34.483 N N 39 N N 116 76 40 34.483 N N 39 N N 116 76 40 34.483 N N 39
142 Elumalai 52 Male 2 Y N Y N N N N N 89 136 86 50 36.765 N N N 39 Y Y Y N N 136 86 50 36.765 N N 39 N N 136 86 50 36.765 N N 40 N N 136 86 50 36.765 N N 40
143 Bhavani 58 Female 2 N N N N N N N N 98 140 90 50 35.714 N Y N 39 Y N N N N 140 90 50 35.714 N N 39 N N 140 90 50 35.714 N N 39 N N 140 90 50 35.714 N N 39
144 Yasodha 54 Female 2 Y N N N N N N N 101 140 100 40 28.571 N N Y 40 N N Y N N 140 100 40 28.571 N Y 40 N N 140 100 40 28.571 N Y 40 N N 140 100 40 28.571 N Y 40
145 Karnal 53 Male 2 N N N N N N N N 85 150 110 40 26.667 N N N 40 Y N Y N N 150 110 40 26.667 N N 40 N N 150 110 40 26.667 N N 40 N N 150 110 40 26.667 N N 40
146 Murugesan 54 Male 2 N N N N N N N N 100 138 90 48 34.783 N Y N 40 Y N N N N 138 90 48 34.783 N N 40 N N 138 90 48 34.783 N N 40 N N 138 90 48 34.783 N N 40
147 Angusamy 72 Male 2 N N Y N N N N Y 99 120 88 32 26.667 N N N 40 Y N Y N N 120 88 32 26.667 N N 40 N N 120 88 32 26.667 N N 40 N N 120 88 32 26.667 N N 40
148 Ramadoss 60 Male 3 N Y N N N N N N 86 112 78 34 30.357 N N N 40 Y N Y N N 112 78 34 30.357 N N 40 N N 112 78 34 30.357 N N 40 N N 112 78 34 30.357 N N 40
149 Hari 43 Male 3 N N N N N N N N 80 128 88 40 31.25 N N N 40 Y N N N N 128 88 40 31.25 N N 40 N N 128 88 40 31.25 N N 42 N N 128 88 40 31.25 N N 42
150 Palani 75 Male 2 Y N Y N N N N N 85 112 78 34 30.357 N N Y 36 Y N N N N 112 78 34 30.357 N Y 36 N N 112 78 34 30.357 N Y 36 N N 112 78 34 30.357 N Y 36
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